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ABSTRACT 
Objectives:  Research indicates a relationship between pregnancy and cardiovascular disease, 
but the cause of this relationship is unknown.  One possible explanation is that there is a 
relationship between pregnancy and vascular change.  The objective of this dissertation is to 
illuminate this relationship by exploring 1) the association between parity and structure of the 
carotid arteries in a population of overweight or obese women of reproductive age and 2) the 
normal course of common carotid artery (CCA) remodeling and changes in stiffness of the 
brachial artery throughout a healthy first pregnancy and postpartum. 
 
Methods:  The first paper provides a cross-sectional analysis of the relationship between 
reproductive factors and structural measures of the carotid artery in overweight and obese young 
women participating in the Slow Adverse Vascular Effect of Obesity (SAVE) clinical trial.  The 
subsequent 2 papers provide results of the Maternal Vascular Adaptation to Healthy Pregnancy 
(MVP) study, in which 43 healthy young women were assessed prospectively throughout their 
first pregnancies with ultrasounds of their carotid arteries, a measure of brachial artery 
distensibility, and physical and metabolic measures.   
 
Results: In the SAVE study, nulliparous women had greater common carotid inter-adventitial 
diameter (IAD) and mean CCA intima media thickness (IMT) compared with parous women 
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after adjustment for age, race, and CVD risk factors.  In the MVP study, after adjustment for age 
and pre-pregnancy BMI, mean IAD increased each trimester and returned to baseline 
postpartum.  Mean CCA IMT was increased postpartum compared to 1st and 2nd trimester values. 
Mean brachial artery distensibility decreased from 1st trimester to 3rd trimester and then 
remained unchanged postpartum. 
 
Conclusions:  Among overweight and obese young women, nulliparity was associated with less 
healthy carotid arteries.  During the course of healthy first pregnancy, some negative vascular 
changes (greater CCA IMT and stiffer brachial arteries) occurred that persisted into the 
postpartum period. 
 
Public Health Significance:  Cardiovascular disease is the leading cause of death in women.  
Early identification of women at high risk (nulliparous) offers early opportunity for risk 
reduction.  Understanding normal vascular changes of pregnancy may help explain the 
pathophysiology of preeclampsia, the cause of 50,000 maternal deaths per year. 
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1.0 INTRODUCTION 
 
There is no more profound example of vascular remodeling, or lasting structural changes 
in blood vessel walls, than that which occurs in the uterine vasculature during the course of a 
healthy pregnancy.  The changes which occur allow the vasculature to nourish the growth of a 
healthy, full-term baby while maintaining the wellbeing of the pregnant woman.  When this 
uterine vascular remodeling occurs incorrectly it can result in pregnancy complications such as 
preeclampsia1, preterm birth1,2, intrauterine growth restriction3-5, and stillbirth6.  While there is 
significant understanding of the changes that occur in the uterine vasculature, much less is 
known about changes that occur in the systemic arteries of pregnant women.  Systemic arteries 
and uterine vasculature both remodel in response to similar stimuli of hemodynamic stressors, 
and hormonal and metabolic influences. Thus, a better understanding of the effects of pregnancy 
on the systemic arteries may contribute to improved detection of women at risk for pregnancy 
complications before or early in pregnancy, help explain racial disparities in birth outcomes, and 
help explain the differences in cardiovascular risk found in women of different parity. 
 
  1.1. VASCULAR REMODELING AND VASCULAR STIFFNESS 
1.1.1 Definitions 
Blood vessels change size to accommodate acute and chronic changes in the body’s 
metabolic needs.  Acutely, blood vessels can dilate to bring increased blood flow to an organ, 
such as to accommodate the needs of skeletal muscle during exercise, or constrict, such as to 
conserve body heat in the cold.  In contrast, when there are long-term changes to the demands on 
the blood vessels they can remodel.7  Vascular remodeling is lasting structural change in blood 
1 
vessel walls in response to hemodynamic, metabolic or hormonal stimuli.8  Size of the vessel 
wall can increase through hypertrophy or hyperplasia of vascular smooth muscle cells, and 
decrease through hypotrophy and apoptosis.  These structural changes are distinct from the 
functional changes of dilation or constriction.8 
The goal of vascular remodeling is to maintain homeostasis of the different hemodynamic 
stresses on the vessel. When this is achieved it is termed adaptive remodeling; when homeostasis 
is not achieved the remodeling is maladaptive.9  Maladaptive vascular remodeling is seen in 
states of ill-health including hypertension, metabolic syndrome,9 chronic kidney disease,10 and 
rheumatoid arthritis.11 
A related concept to vascular remodeling is vascular stiffness, or the elastic properties of 
the vessel wall.12  Vascular stiffness depends both on structural properties of the vessel such as 
wall thickness and composition and functional properties such as changes in diameter and 
endothelial function.13  Reflection of these two components allows vascular stiffness to be 
viewed as a summary measure of vascular health.14   
 
1.1.2 Assessment of Vascular Remodeling 
The arterial wall is comprised of 3 layers: the intima, the media and the adventitia.  The 
inner layer is the intima, which consists of a single layer of endothelial cells on a thin 
extracellular matrix.  The intima separates the blood from the structural part of the vessel, and 
regulates flow of nutrients and blood components.15  It is also metabolically active and involved 
with hemostasis, inflammation and angiogenesis, and is the site of atherosclerotic plaque 
formation.  The middle layer, or media, is the main structural component of blood vessels and is 
formed of smooth muscle cells surrounded by an extracellular matrix of collagen, elastic fibers, 
2 
fibroblasts, and an internal elastic lamina.15  The adventitia is the outer layer of the blood vessel 
and is a network of connective tissue, elastin, collagen, nerves and blood vessels. 
This dissertation primarily concerns remodeling of the carotid artery.  The paired 
common carotid arteries (CCA) are the main source of blood flow to the head.  While paired, the 
arteries are not completely symmetrical.  The left common carotid artery branches directly off 
the aorta and the right common carotid branches off the brachiocephalic artery, which originates 
in the aorta.16  Both common carotid arteries widen into the carotid bulb and divide into the 
internal carotid artery (ICA), carrying blood to the brain, and the external carotid artery, carrying 
blood to the scalp and face.16 
While many modalities can be used to image the carotid artery, this dissertation focuses 
on ultrasound assessment.  Ultrasound assessments of the carotid artery are highly reproducible, 
valid, and used frequently in epidemiologic research studies and increasingly in clinical 
practice.17  The Ultrasound Research Laboratory at the University of Pittsburgh uses B-mode 
ultrasound with high frequency linear array transducers to image the carotid arteries for 
measurement of intima-media thickness (IMT), the thickness of those 2 wall layers, and inter-
adventitial diameter (IAD), the distance from near wall adventitial medial-interface to far wall 
adventitial-medial interface.  Images are digitally recorded and read with an automated reading 
system.18  This modality can also assess presence and extent of plaque formation. 
 
1.1.3 Assessment of Arterial Stiffness 
Arterial stiffness can be measured along any branch of the arterial system.  Aortic, or 
central, stiffness is most commonly assessed, but peripheral stiffness can be assessed in the 
arteries of the arm and leg.  There are many indices of arterial stiffness, including elastic 
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modulus, Young’s modulus, arterial distensibility, arterial compliance, pulse wave velocity, 
augmentation index, and stiffness index.19  These can be assessed with ultrasonography, 
magnetic resonance imaging, or pressure waveform analysis.19  Studies of arterial stiffness in 
pregnancy have most often utilized pressure waveform analysis to measure augmentation index, 
the difference between the first and second systolic peak divided by pulse pressure, and pulse 
wave velocity (PWV), the speed of travel of the pulse wave along an artery, measured as 
distance over time.19  Both greater augmentation index and pulse wave velocity are associated 
with greater arterial stiffness. 
This dissertation is primarily concerned with measurement of brachial artery 
distensibility.  Distensibility is the relative change in arterial diameter for a given change in 
pressure.19  In the Maternal Vascular Adaptation to Healthy Pregnancy Study we utilized the 
DynaPulse 2000A system to derive brachial artery distensibility from analysis of the pressure 
waveforms in the brachial artery.  This technique has been found to be reliable when compared 
to invasive monitoring techniques.20 
 
1.1.4 Significance of Intima Media Thickness and Adventitial Diameter 
IMT and IAD are both markers of several dimensions of arterial health, with greater 
diameter and thickness representing less healthy vessels.  IMT is thickened in the presence of 
atherosclerotic plaque, but IMT is much more than a marker of plaque and can thicken without 
its presence.21  Both IMT and IAD tend to increase with age,22 on average doubling to tripling 
between 20 and 90 years of age,21 but there is wide variation in this increase between different 
individuals and cultures.  IMT and IAD mark cumulative exposure to cardiovascular risk factors, 
and are increased by many of the same factors that cause atherosclerosis.  Similar physiologic 
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processes lead to thickened IMT and atherosclerosis.21  Thickened IMT and IAD also can 
become risk factors for cardiovascular disease, because thickened, distended vessels are less 
capable of responding effectively to changes in blood pressure,23 and thickened arteries are most 
prone to the development of atherosclerosis.13 Thus, IMT and IAD are measures of arterial health 
because they describe extent of plaque and cardiovascular risk factor burden, but also because 
they are their own innate measures of vascular health. 
Many studies document the relationship between IMT and IAD and traditional 
cardiovascular risk factors.  Greater IMT is found with male sex,22,24  greater systolic blood 
pressure,22,24,25 cigarette smoking,22,24,25 higher total cholesterol,22 higher LDL-c cholesterol,24,25   
higher triglycerides,22 and higher blood glucose.22  Greater IAD is found with male sex,26,27 black 
race,26 increasing weight,26,27 greater height,27 higher blood pressure,27 higher blood glucose,27 
alcohol use,27 higher triglyceride levels,27 and lipid-lowering medication use,26 and negatively 
associated with HDL-c concentrations.26,27  All these relationships are in the direction one would 
expect if the traditional cardiovascular risk factors affect IMT and IAD. 
Intima-media thickness and IAD both independently predict cardiovascular disease risk 
beyond the mere presence of traditional cardiovascular risk factors.  Greater IMT is related to 
higher risk of myocardial infarction,28-32 coronary artery disease endpoints,33-35 and 
cerebrovascular disease endpoints. 30,33,36-38    Greater IAD is related to higher risk of 
cerebrovascular disease,33  and incident cardiac events.39  Assessment of IMT and IAD thus 
provides assessment of vascular health and levels of cardiovascular risk factors, and assists in 
prediction of future health outcomes.17 
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 1.1.5 Significance of Arterial Stiffness 
Greater arterial stiffness (or lower compliance and distensibility) is a marker of arterial 
aging and less healthy vasculature.  Both structural and functional arterial changes lead to 
increased stiffness.14,21   Structural changes include thickened arterial wall, increased collagen 
content, fragmentation of elastin, and calcification.21  Functional changes include decreased 
endothelial function.21  Greater arterial stiffness is associated with known cardiovascular risk 
factors including greater age,21,40 obesity,40 sodium intake, 14,41 abnormal glucose 
metabolism,14,41 chronic renal disease,14 and hypertension,41-43  and is associated with greater 
coronary heart disease,44-46 stroke,44 cardiovascular mortality,44,46 and all-cause mortality.44-46 
Stiffness can be measured in any arterial bed but is most often assessed in the central 
aorta and carotid, brachial and femoral arteries.  Aortic stiffness has traditionally been viewed as 
of the greatest importance because it contributes to the development of isolated systolic 
hypertension, congestive heart failure, and inadequate perfusion of the coronary arteries.12,14  
Measures in the peripheral arteries (brachial and femoral) have often been seen merely as 
reflecting central stiffness.47  More recent research supports examining the different arterial beds 
separately.  Arterial stiffness is lowest in the central bed (aorta) and higher in peripheral arteries 
(brachial and femoral).12  Anatomically the vessels differ, with the aortic wall primarily elastic, 
the brachial artery wall more muscular, and the femoral artery a combination of the two.48  Risk 
factor association differs for different regions.  Compared to peripheral stiffness, central stiffness 
is more associated with weight/body mass index.49  Peripheral stiffness is more associated with 
age and glucose metabolism.49,50  A recent study demonstrated differences in the ability of 
stiffness in different arterial beds to predict outcomes.45   It found that greater carotid and 
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femoral stiffness were associated with cardiovascular events and all-cause mortality, while lower 
brachial stiffness predicted events and mortality only in people with insulin resistance.45 
 
1.2 IMPORTANCE OF UNDERSTANDING VASCULAR CHANGES OF PREGNANCY 
 
1.2.1 Pregnancy Complications with Vascular Components 
Many pregnancy complications have a vascular component.  The spiral arteries of the 
uterus, which carry blood to the placenta, are remodeled during pregnancy by systemic factors 
and invasion of trophoblast cells to become greatly enlarged, and bring large amounts of blood to 
the placenta at low pressure.  Failure of this remodeling is a precipitating factor for the 
development of preeclampsia, preterm birth, and intrauterine growth restriction.1-5,51,52  Of 
interest, failure of spiral artery remodeling is not sufficient to cause disease.  Approximately half 
of women who have inadequate remodeling, as demonstrated by abnormal uterine artery blood 
flow measured by Doppler ultrasound at about 20 weeks of gestation, do not develop pregnancy 
complications.53  Many women with abnormal uterine artery blood flow do not exhibit abnormal 
spiral artery remodeling on placental biopsy.54 
Preeclampsia is a pregnancy-specific disease complicating 2-8% of pregnancies,55  
defined by new origin hypertension and proteinuria occurring after 20 weeks of pregnancy.  It is 
a multi-system disorder that can also include liver damage, kidney damage, hematological 
changes such as hemolysis and destruction of platelets, neurological symptoms such as 
headaches and seizures, and intrauterine growth restriction for the fetus.  While the cause of 
preeclampsia is not fully understood, there appear to be three stages: a maternal predisposition to 
abnormal placentation and failed spiral artery remodeling ,the abnormal placentation and failed 
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spiral artery remodeling themselves, and then pathologic maternal response to the failed 
remodeling.53  Maternal factors that may both predispose to abnormal placentation and increase 
likelihood of developing preeclampsia once the abnormal placentation has occurred may include 
factors such as endothelial dysfunction, insulin resistance, obesity, preexisting hypertension, 
dyslipidemias, lifestyle and genetic factors.52,53 
There is no effective treatment for preeclampsia except delivery.  The whole system of 
prenatal care in the developed world is largely designed to facilitate early detection of 
preeclampsia, and maternal deaths from preeclampsia in the US are relatively rare.  Preeclampsia 
contributes to 16% of maternal deaths in developed countries and up to 23% of maternal deaths 
in Latin America.56  Most of the 50,000 maternal deaths each year from preeclampsia occur in 
the developing world, where women do not have access to prenatal care or labor induction to 
treat developing preeclampsia.57  Preeclampsia also contributes to perinatal mortality and 
morbidity, and contributes to 12% of growth restricted and up to 20% of preterm infants.57   
Preterm birth is any birth before 37 completed weeks of pregnancy.  There are many 
causes of preterm birth including infection/inflammation, trauma and maternal or fetal medical 
indications.58 Failed spiral artery remodeling appears to occur in about 1/3 of preterm births.1,2,59  
Preterm birth occurs in approximately 12% of US births.60  Babies born preterm have 
disproportionately greater morbidity and mortality. Compared to babies born full term, babies 
born at 34-36 weeks gestation have 3.5 times greater mortality, and those born even earlier have 
a 50 times greater mortality.60  Babies born prematurely have higher risk of lifelong health and 
neurodevelopmental problems.61 
Fetal growth restriction is diagnosed when a fetus or newborn has a weight below the 10th 
percentile for its gestational age.62 Estimates of prevalence, morbidity, and mortality for growth 
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restricted babies are difficult because growth restriction cannot be differentiated from 
prematurity in many large population studies, and the National Center for Health Statistics does 
not separate out growth restricted from other small babies in its birth data.60  Growth restricted 
babies have higher mortality and long term neurodevelopmental impairment than normally 
grown babies.63 Abnormal placentation is a known cause of growth restriction.3-5   
In the United States approximately 1 in 160 births results in stillbirth, or fetal death after 
20 weeks of pregnancy.6  Evidence of vascular maladaptation is less clear than with the other 
pregnancy complications discussed, but a study supports that defective first trimester 
placentation is associated with stillbirths.64  A population-based study of stillbirth in the United 
States found that placental disease was a probable/possible cause of 22% of stillbirths, and that 
umbilical cord abnormalities were a probable/possible cause of 13%.6 
 
1.2.2 Pregnancy’s Association with Changes in CVD Risk Factors 
Pregnancy is associated with life-long changes in CVD risk factors.  Most studies on the 
topic are cross-sectional in design and cannot fully assess temporality, however existing data 
suggest that some changes seem to accumulate with each pregnancy, some are one time changes 
with first births, and for others little is known.65,66  Many of these changes are related to 
metabolism and would be expected to have a negative effect on cardiovascular health.  A large 
study using NHANES data in the US found a linear relationship between parity and prevalence 
of metabolic syndrome.  In all women except non-Hispanic black women each additional live 
birth was associated with 13% higher odds of having metabolic syndrome.67   Parity was 
associated with greater waist circumference, lower HDL-c and higher triglyceride 
concentrations, but not with blood pressure or glucose concentrations.  Similar results were 
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found in a Chinese sample, except this study also found higher fasting glucose concentrations 
with each birth.68  It seems likely that changes in body fat composition including increased waist 
to hip ratio and abdominal adiposity are related to these changes.69-71 Visceral abdominal fat is 
believed to  increase insulin resistance more than peripheral fat via mechanisms including higher 
lipolysis, leptin resistance, and inflammatory cytokines, and lower adiponectin levels.72  A study 
on the relationship between parity and inflammatory markers found no relationship with 17 
inflammatory markers.73 
A prospective study in the US suggests that some CVD risk factors demonstrate a “first 
birth effect” with long-lasting one-time changes after first births which are not repeated after 
subsequent births.  These include a decline in HDL-c of 3-4 mg/dl,65 and paradoxically, the 
beneficial change of a 2 mm Hg drop in systolic and diastolic blood pressures after a first birth 
among women with a non-hypertensive pregnancy.66  LDL was found to drop about 4 mg/dl after 
a first birth, but this difference was not statistically significant after accounting for changes in 
smoking status, months of oral contraceptive use, education, body weight, waist circumference, 
physical activity and alcohol intake.65 
Understanding how pregnancy affects CVD risk factors may allow for interventions 
during pregnancy and postpartum to mitigate the negative effects of pregnancy on CVD risk 
factors. 
 
1.2.3 Pregnancy as a CVD Risk Factor 
Pregnancy itself may be a CVD risk factor.  Studies of the relationship between gravidity 
or parity and cardiovascular disease have had varied results,74 but the largest studies show 
greater risk of CVD for women of high parity.75-78  The largest population-based cohort study 
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followed 1.3 million Swedish women for 9.5 years, and found a j-shaped relationship between 
parity and CVD events.77  Women with parity of 2 have the lowest CVD risk.  Nulliparous and 
primiparous women both have about a 10% higher risk.  Risk then increases with parity, so that 
women with 5 or more births have a more than 50% greater CVD risk than women with 2 births.  
The authors postulate that higher risk in women of low parity is secondary to confounding from 
subfertility in that population.  Subfertility has many possible causes, one of which, an elevated 
ratio of androgens to estrogens, may plausibly be associated with CVD risk.79 Greater risk in 
women of high parity may be related to accumulation of CVD risk factors with each pregnancy.  
A significant difficulty with studies of parity is that parity is closely connected to various socio-
economic factors that may also be associated with CVD risk, and which are difficult to control 
for in research studies.80  A recent study of 500 very homogeneous Old Order Amish women 
with mean parity of 6.7 found no relationship between parity and CVD, even though higher 
parity was associated with greater BMI.81  This suggests that residual confounding due to socio-
economic factors may be a cause of the greater CVD risk found in women of higher parity. 
Studies of examining number of children and cardiovascular disease risk in men 
illuminate this relationship.  A US study found a U-shaped relationship between number of 
children and cardiovascular mortality with the nadir at 2 children; after adjustment for socio-
economic risk factors only men with no children or one child continued to have greater risk.82  A 
study comparing men with and without children also found greater risk of mortality from 
ischemic heart disease for childless long-term cohabiting men.83  Intima media thickness has not 
been shown to vary by number of children in men84 and may decrease with the birth of a child.85   
These findings suggest that subfertility may be associated with cardiovascular disease in men as 
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well as in women, and that higher incidence of cardio-vascular disease for men with more 
children might be due to confounding from socio-economic status. 
 
 
 
1.3 STIMULI FOR VASCULAR REMODELING AND THE EFFECTS OF 
PREGNANCY 
 
Stimuli for vascular remodeling include hemodynamic, hormonal and metabolic factors.  
All of these factors are affected by pregnancy in ways that should influence vascular remodeling. 
 
1.3.1 Hemodynamic Changes 
Arterial walls attempt to maintain homeostasis between the two main stresses from blood 
flow: shear stress and tensile stress.  Shear stress is the tangential or frictional force of blood 
flowing along the intima of the artery.  The adaptive response to shear stress is for the diameter 
of the blood vessel to increase.7,8,86  Tensile stress is the force of blood perpendicular to the wall 
of the artery.  The adaptive response to tensile stress is for the wall thickness to increase.7,87  In 
the healthy individual diameter and wall thickness change in concert to normalize stress in 
response to flow changes.  Typically, increased blood flow leads to increased diameter.  This 
then increases tensile stress, which leads to thickening of the vessel wall, maintaining 
homeostasis.23  Wall thickening increases arterial stiffness.21 
Pregnancy involves massive hemodynamic changes that increase shear stress on the 
blood vessels (Table 2.1).  Cardiac output increases by early in the first trimester of pregnancy88 
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peaking at 30-60% above the non-pregnant level in the late 2nd or early 3rd trimester.88-91  The 
increase is caused by elevation of plasma volume, which increases by about 35-45%,88,89,91,92 
leading to increased stroke volume88,89 and also from an increased heart rate of about 10-15 beats 
per minute.93-95  Some studies show that cardiac output remains elevated 1 year postpartum.90  
Greater increases in blood volume are found in women of higher BMI, higher parity, with larger 
fetuses, and with multiple gestations.92  While mechanisms of the increased plasma volume are 
not fully understood, it is theorized that fetal dehydroepiandrosterone sulfate (DHEAS) 
production stimulates the renin-angiotensin-aldosterone system to retain sodium and water.96 
Pregnancy is also characterized by decreased systemic vascular resistance.  This 
decreases by the 8th week of pregnancy88 and reaches a nadir of about a 35% decrease in the 2nd 
trimester.89,93,94  It remains below baseline 1 year postpartum.90  Following this decrease, blood 
pressure also decreases in early pregnancy.  There is a 10% decrease in mean arterial pressure by 
the 8th week of pregnancy, primarily driven by decreased diastolic pressure.  The nadir of blood 
pressure occurs during the second trimester, and blood pressure increases to baseline at 
term.88,90,91,94,97  Mechanisms for decreased systemic vascular resistance are theorized to include 
increased concentrations of vasodilatory prostanoids such as prostacyclin,98 increased 
concentrations of nitric oxide,99 vasodilatory effects of the renin-angiotensin-aldosterone 
system,98 the development of the low-resistance placental bed,88 and local vasodilation in 
response to heat produced by the fetus.88  The combination of increased blood volume and 
decreased systemic vascular resistance increases the velocity with which blood passes through 
the vasculature.  This in turn increases the shear stress on the blood vessels. 
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 1.3.2 Reproductive Hormones  
An increasing body of research, much of it done in mid-life or older women, suggests 
that reproductive hormones play a role in vascular remodeling.  Use of menopausal hormone 
therapy has been shown to be independently associated with thinner CCA IMT,100 ICA IMT,101 
CCA adventitial and lumen diameter,102  and greater arterial compliance.103,104  CCA IMT and 
lumen diameter have been found to be greater in post- than pre-menopausal women,105  
suggesting that estrogen has a protective effect.  The most comprehensive study found no 
relationship between endogenous estradiol concentrations and baseline IMT or IMT progression 
in middle-aged women, but did find that higher estrogen levels were associated with lower 
baseline adventitial diameter,106 and slower progression of adventitial diameter over time.107 In 
general, arterial stiffening increases after menopause, suggesting a hormonal link.103,104,108 
Additionally, higher testosterone concentrations are associated with thicker CCA IMT in women 
in some studies,109,110 but not others.111-113  Sex hormone binding globulin has been found to be 
negatively associated with IMT.107,111,114 
Direct mechanisms by which reproductive hormones may affect vessel walls are unclear.  
Vessel walls express receptors for estrogen, progesterone and testosterone.115  Estrogen appears 
to have anti-inflammatory effects on blood vessel walls.116 Reproductive hormones might also 
affect the connective tissue component of blood vessel walls.  In vitro, aortic smooth muscle 
cells incubated with estradiol, progesterone, and testosterone all had lower collagen deposition 
than cells incubated with a control solution.  Elastin concentrations were higher in the cells 
incubated with estradiol and progesterone.117  Lower collagen and higher elastin concentrations 
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would be expected to produce less stiff arteries.  Also in vitro, estrogen appears to inhibit 
vascular smooth muscle cell proliferation, which could decrease atherosclerosis.115 
Pregnancy induces dramatic increases in concentrations of sex hormones.  Estrogen 
concentrations increase more than 100-fold in pregnancy.118  Estrogen is initially produced 
maternally by the ovaries, adrenal glands, and peripheral conversion of androgens to 
estrogens.119  Estrogen production is then assumed by the placenta.119  Progesterone 
concentration increase hundreds of times throughout the course of pregnancy.118  Progesterone is 
produced initially by the maternal corpus luteum; by about 10 weeks of pregnancy the placenta 
assumes production of progesterone and the corpus luteum degrades.119,120 Total testosterone 
concentrations increase throughout pregnancy; free testosterone concentrations remain stable 
initially, but approximately double in the third trimester.121   Human chorionic gonadotropin, a 
hormone unique to pregnancy, is produced by the trophoblast cells by 8 days after conception, 
peaks at 8-12 weeks of pregnancy, and then is present at lower concentrations throughout 
gestation.118  Additionally, maternal cortisol concentrations roughly double during pregnancy.122  
These hormonal changes plausibly can affect the vasculature. 
 
1.3.3 Metabolic Changes 
An increasing body of research shows that metabolic factors are related to IMT, intra- 
adventitial diameter, and arterial stiffness.  Greater IMT and/or IAD have been shown to be 
independently associated with treated diabetes mellitus,26 glucose concentrations,123-126 and 
insulin resistance.125  Some research suggests that spikes in glycemic concentrations may be 
more important than total blood glucose concentrations in affecting IMT.123,127  There are several 
mechanisms by which higher blood glucose concentrations affect vessel walls.   They increase 
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oxidative stress,127  affect the structure of extracellular matrix proteins, and reduce bioavailability 
of  NO produced by the endothelium.128  Impaired glucose metabolism is also linked with arterial 
stiffness, largely due to increased collagen cross-links in the vessel wall caused by glycation.14,21  
Lipid concentrations also affect the vasculature both by promotion of atherosclerosis and through 
direct effects.  Greater IMT and adventitial diameter have been shown to be greater in people 
with lower HDL,26,125,126,129 higher total cholesterol,25,26,126 higher LDL,24,86,105,125 and lipid-
lowering medication use.26  Inflammation is related to greater arterial stiffness because it leads to 
a higher  ratio of collagen to elastin in the vessel wall.14 
Pregnancy is accompanied by atherogenic metabolic changes (Table 2.1).  While insulin 
sensitivity may be slightly increased in early pregnancy, as pregnancy progresses insulin 
resistance develops.  Mean glucose concentrations are similar in pregnant and non-pregnant 
women, but pregnancy is characterized by slightly lower fasting values, higher post-prandial 
values, and 3 times higher insulin concentrations.130  Lipid concentrations dip slightly in early 
pregnancy, and then increase dramatically.  The greatest increase is in triglyceride 
concentrations, but total cholesterol, LDL-c, and HDL-c also increase.131  Pregnancy is an 
inflammatory state, with elevated concentrations of C-reactive protein,132 platelet activation,133 
most blood clotting factors,134 and activated neutrophils.135 
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 1.4 UTERO-PLACENTAL VASCULAR REMODELING IN PREGNANCY 
 
1.4.1 Uterine Artery Remodeling 
Arterial remodeling is evident in the arteries supplying the uterus.  These arteries undergo 
dramatic changes as blood flow to the uterus increases from 20-50ml/min in the non-pregnant 
state to 450-800m/min in a singleton pregnancy. 136,137  In response, the diameter of the uterine 
artery approximately doubles,136,138 and diameters of the other arteries increase as well, an 
example of outward hypertrophic remodeling.  It appears that vascular smooth muscle cell 
increase in both number and size to accomplish this remodeling.138  
While not fully understood, mechanisms behind this remodeling seem to be both 
systemic and localized and follow general principles of vascular remodeling.  Systemic 
influences include the increased concentrations of estrogen and progesterone in pregnancy 
(indeed, uterine artery blood flow increases from day 10 of the menstrual cycle).122,139  Several 
lines of experimental research suggest that this is the first instigator of change.138  As pregnancy 
progresses, localized mechanisms including shear stress and presence of growth factors produced 
by the placenta such as vascular endothelial growth factor may be responsible.  Both hormonal 
and shear stress mechanisms may affect arterial diameter by up-regulating endothelial nitric 
oxide.   Estrogen and progesterone both affect growth factor secretion136 and estrogen stimulates 
DNA synthesis and mitosis in uterine radial arteries.138 
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 1.4.2 Spiral Artery Remodeling 
Even more profound remodeling is seen in the changes that occur in spiral arteries, the 
last maternal vasculature before the placenta.  These arteries become greatly dilated and lose 
smooth muscle, allowing them to bring modestly increased amounts of blood at low pressure to 
the placenta.118   
Remodeling of the spiral arteries likely begins with the same stimuli as other remodeling 
– the increased reproductive hormone concentrations of pregnancy, including human chorionic 
gonadotropin, estrogen and progesterone, and increased shear stress.118,140,141  But the principle 
mechanism of this remodeling is unique – invasion of spiral arteries by extravillous trophoblast 
cells (EVT). The EVT leave the placental villi and invade the decidual stroma, colonizing the 
spiral arteries both from the outside (interstitial invasion) and by migrating inside the lumen of 
the vessels (endovascular invasion.)142  The vessel endothelium and vascular smooth muscle 
cells are replaced by the EVT.136   
The effect of metabolic factors on spiral artery remodeling is more difficult to determine.  
Both blood glucose and lipid concentrations may be involved.  It is known that women with 
diabetes have higher incidence of pregnancy complications involving inadequate spiral artery 
remodeling than do women without diabetes, suggesting that hyperglycemia may play a role.143  
Small studies have found higher incidence of poor spiral artery remodeling in diabetic than in 
non-diabetic women 144 and in diabetic women with worse glycemic control.145  Lipids might 
also be involved in spiral artery remodeling.  The relationship between lipid concentrations and 
preeclampsia has not been fully elucidated.  Some studies show elevated pre-pregnancy lipid 
concentrations in women who will develop preeclampsia146-148 and there is clear evidence of 
18 
higher pregnancy lipid concentrations in women who will develop preeclampsia.131,149  Spiral 
arteries that remodel incompletely contain lipid deposits resembling atherosclerosis.150,151  It is 
unclear whether the lipid abnormalities contribute to inadequate remodeling of spiral arteries, or 
if abnormally remodeled arteries are sensitive to the effects of elevated lipid concentrations.151 
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1.5 STUDIES OF SYSTEMIC VASCULAR REMODELING ASSOCIATED 
 WITH PREGNANCY 
1.5.1 Anatomic Data 
Few studies have examined structural changes in systemic arteries during pregnancy, but 
those that exist suggest that there are substantial changes.  Histologic studies have found that in 
guinea pig carotid arteries there is progressive thinning of the intimal and medial layers 
throughout pregnancy, caused by hypotrophy of both smooth muscle and endothelial cells,152 
while the aorta demonstrates only a thinning of the intima, again associated with endothelial 
hypotrophy.153  In contrast, guinea pig femoral arteries showed no change.154  Human studies 
have found that the aorta has greater diameter and is more elastic during pregnancy.155 
1.5.2 Cross-Sectional Studies of IMT in Healthy vs. Complicated Pregnancies 
A number of small cross-sectional studies compared IMT in healthy and complicated 
pregnancies (Appendix 1, Table 6.1).  Studies showed that women who had pregnancies 
complicated by preeclampsia had greater CCA IMT at 3-13,156 and 12-24157 months, and greater 
mean IMT 25 years158 postpartum than women with uncomplicated pregnancies, after adjustment 
for traditional cardiovascular risk factors.  Other studies showed no difference in CCA IMT 
between women with preeclampsia and women with normal pregnancies at 5159 or 7 years 
postpartum.160   A study comparing women at high risk for development of preeclampsia because 
of elevated uterine artery pulsatility indices at 20-23 weeks of gestation to women with normal 
indices found no difference in mean CCA IMT, but significantly greater mean ICA IMT in 
women with the at-risk pregnancies.161 A study that compared women with preeclampsia at term 
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to women with uncomplicated pregnancies found greater CCA IMT and internal diameter in the 
women with preeclampsia.162 
Several studies compared women with gestational diabetes to women with non-diabetic 
pregnancies (Appendix 1, Table 6.2).  One found that women with gestational diabetes had 
greater CCA IMT at 25 weeks of pregnancy,163 and another that the mean of CCA and ICA IMT 
was greater in women with gestational diabetes in both the 2nd and 3rd trimesters.164   At 3 years 
postpartum a small study found no difference in CCA IMT when women were matched for 
BMI165 but a larger, age-matched sample from the same group did find greater CCA IMT in the 
women with gestational diabetes at 3 years postpartum.166 Other studies found significantly 
thicker IMT (mean of all segments) in women with gestational diabetes at 2-3 years 
postpartum,167 and at 6 years postpartum (mean of CCA and ICA)168 but not statistically 
significantly greater at 4 years postpartum.169  These women had IMT comparable to a 
comparison group with metabolic syndrome.  A study dividing women with gestational diabetes 
into those with more mild disease not requiring insulin and more severe disease requiring insulin 
found greater CCA IMT at 3 months postpartum only in women who required insulin.170 
The preponderance of research on this topic suggests that women with pregnancies 
complicated by preeclampsia or gestational diabetes may have greater IMT and possibly CCA 
diameter during pregnancy and postpartum than women with normal pregnancies.  The cross-
sectional nature of these studies makes it impossible to assess temporality.  Is greater IMT a 
marker for women who are at risk of pregnancy complications?  Or do the pregnancy 
complications themselves cause the greater IMT?  Or does a process that goes wrong in 
pregnancy create both the complication and the greater IMT?  Longitudinal studies are needed to 
answer these questions. 
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 1.5.3 Prospective Studies of IMT in Pregnancy 
Prospective data on changes in the carotid artery throughout the maternity cycle are 
limited.  One study followed 23 women throughout their pregnancies and 11 into the postpartum 
period, and found that CCA IMT and diameter both increased slightly from the first to the third 
trimester, and then decreased at 3-6 months postpartum, although remaining above baseline 
measures.  The only significant difference was in IMT between the 1st and 3rd trimesters.171 A 
second study by the same group of researchers followed 12 women and found both CCA IMT 
and diameter increased throughout pregnancy and decreased postpartum, although the 
differences were only significant for diameter.172  Another group found no difference in the mean 
of the CCA and ICA IMT between the 2nd to 3rd trimesters in either healthy pregnancies or 
pregnancies complicated by gestational diabetes.164    A study that measured IMT at 2 time 
points 6 years apart found an increase of mean and maximum CCA IMT in women for each child 
born during the time period.85  While prospective data is lacking, it does suggest that pregnancy 
results in increased carotid IMT and diameter, which recedes postpartum, although not back to 
pre-pregnancy measures. 
 
1.5.4 Intima vs. Media 
Two studies assessed the carotid wall during pregnancy using extremely high-frequency 
ultrasound imaging that can differentiate the intima from the media.  A cross-sectional study 
using this method found that while IMT was identical in women at 39 weeks of pregnancy and a 
healthy non-pregnant control group, the pregnant women had significantly thinner intimas and 
thicker medias.173  In contrast, a recent study utilizing this method to assess women during each 
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trimester of pregnancy and at a year postpartum found changes neither in CCA IMT throughout 
pregnancy, nor in the individual components or ratio of intima to media. All of these decreased 
significantly at 1 year postpartum.174  This was the only study to examine predictors of IMT in 
pregnancy.  It found that lower concentrations of serum estradiol, older age, higher BMI and 
blood pressure were associated with thicker intima, thinner media, and higher ratio of intima to 
media.  The authors state that a higher intima to media ratio is associated with atherosclerosis, 
and that it is logical that these traditional cardiovascular risk factors are related to the ratio in 
pregnant women. 
These studies cannot be compared to the rest of the literature.  This ultrasound technique 
has been used primarily by one research group and has not been validated against the more 
standard technique.  In many cases, investigators using this protocol image only the near wall of 
the common carotid artery, whereas the standard technique images near and far wall, or far wall 
only (a more valid and reliable measure of IMT), and also takes fewer measurements than the 
standard protocol of imaging intima and media together. 
 
1.5.5 Cross-Sectional Studies of Parity and IMT in Midlife and Older Women 
Three cross-sectional studies examine the relationship between parity and IMT in midlife 
and older women.  Two found greater CCA IMT with higher parity after adjustment for 
demographic and traditional cardiovascular risk factors.175,176  One of these also found thicker 
IMT in nulliparous women176 while the other did not.  The third study found no relationship 
between parity and the mean of CCA and bulb IMT.177  These differences may be explained by 
the different measures used. The studies measuring CCA IMT found thicker IMT with higher 
parity, while the study measuring the mean of CCA and bulb IMT did not.  IMT in the different 
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carotid regions reflects somewhat different processes, with bulb IMT more reflective of lipid 
concentrations and atherosclerosis and CCA IMT more reflective of arterial aging.  The two 
studies measuring CCA IMT differed significantly in the percentage of nulliparous women in 
their samples.  The Study of Health in Pomerania, which showed greater IMT in nulliparous 
women, had 8.5% nulliparity, while the Rotterdam Study, showing no effect, had 20% 
nulliparous women.  The authors suggest that the nulliparous women in the Pomerania Study 
may represent women with true infertility, as 8.5% is close to the figure of infertility in the 
general population, and that their greater IMT may be due to atherogenic factors that accompany 
some infertility such as higher androgen and glucose concentrations.178  The 20% of women who 
were nulliparous in the Rotterdam Study may include a large percentage of women who were 
nulliparous by choice.  These 3 studies suggest that women of higher parity and nulliparous 
women with fertility problems may have greater CCA IMT. 
 
1.5.6 Studies of Arterial Stiffness in Healthy versus Complicated Pregnancies 
Many studies have demonstrated an association between greater arterial stiffness and 
preeclampsia.  A 2011 systematic review and meta-analysis included 23 studies  of arterial 
stiffness in women with or after preeclampsia compared to women with healthy pregnancy.47  
The meta-analysis found a greater standard mean difference (SMD) of arterial stiffness measure 
between women with and without preeclampsia (SMD 1.62, 95% CI 0.73-2.50).  This significant 
increase held for measures of central stiffness: carotid-femoral pulse wave velocity (weighted 
mean difference (WMD) 1.04, 95% CI 0.34-1.74) and augmentation index (WMD 15.10, 95% 
CI 5.08-25.11).   
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This dissertation research includes a measure of peripheral stiffness, brachial artery 
distensibility.  Less research is available on measures of peripheral stiffness and preeclampsia.  
While peripheral stiffness reflects central stiffness, it is also influenced by different factors that 
might give insights into different mechanisms of arterial remodeling.  In the meta-analysis 
above, the measure of peripheral stiffness, carotid-radial PWV, was non-significantly higher in 
women with preeclampsia (WMD 0.99, 95% CI -0.07 – 2.05).  Two of three studies179,180 
included in the carotid-radial PWV analysis showed  significant increases; the one that did not 
included only 6 women with preeclampsia.161   All three of the studies included examined PWV 
during pregnancy; the one that included a postpartum measure found no significant difference at 
7 weeks postpartum.179  Other studies, summarized in Table 2.5, using peripheral or mixed 
measures, found stiffer arteries during pregnancy for women with or preceding preeclampsia 
compared to women with healthy pregnancies181,182, and immediately postpartum (3-5 days)181 
but not later postpartum,181,183 although one showed a trend towards higher peripheral PWV 
velocity in postpartum women after preeclampsia.183 
 
1.5.7 Prospective Studies of Arterial Stiffness in Healthy Pregnancy 
Early studies demonstrated that the aorta is more compliant in pregnancy, leading to 
general statements about decreased vascular stiffness in healthy pregnancy,155 but more recent 
longitudinal studies suggest that there are changes in stiffness over the course of pregnancy, and 
that changes may differ between arterial beds. Two studies have shown the brachial-ankle PWV, 
aortic augmentation index, carotid-femoral PWV and carotid-radial PWV are either stable or 
drop between the first and second trimesters of pregnancy, then increase in the third trimester 
and remain elevated postpartum.179,181   In contrast, another group found that carotid-femoral 
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PWV dropped throughout pregnancy (indicating decreased stiffness), while the carotid 
compliance and distensibility both dropped (indicating increased stiffness).172  The latter study 
supports earlier work by the same group that also demonstrated carotid stiffening.171 
 
 
1.6 GAPS IN KNOWLEDGE AND GOALS OF DISSERTATION 
 
The theoretical framework for this dissertation is Holly Powell Kennedy’s Model of 
Exemplary Midwifery Practice.184  This model highlights midwifery’s belief in and respect for 
pregnancy and childbirth as normal processes.  Research into these normal processes is 
respectful of women, contributes to women achieving optimal health, and enhances the 
profession of midwifery. 
The complex interplay between cardiovascular risk factors, acute and long-term 
hemodynamic, metabolic, and hormonal changes of pregnancy, utero-placental vascular 
remodeling, systemic vascular remodeling, pregnancy complications, and CVD risk, is 
represented as a conceptual model in Figure 1.5.  Factors such as age, race and BMI influence 
pre-pregnancy uterine and systemic vasculature.  During pregnancy, acute changes in 
hemodynamics, metabolism and hormone concentrations influence remodeling of both the utero-
placental and systemic vasculature; invasion by EVT cells plays a major role in remodeling of 
the spiral arteries in the decidua.  The adequacy of the remodeling of the utero-placental 
vasculature influences risk of pregnancy complications; remodeling of the systemic vasculature 
may also affect this risk.  Postpartum, both parts of the vasculature change, but it is unclear if 
they return to baseline levels.  The baseline structure of the systemic vasculature, the changes 
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that happen to it during pregnancy, and the effect of long-term hemodynamic, metabolic and 
hormonal changes after pregnancy influence remodeling of the vasculature after childbearing, 
which then affects CVD risk. 
Some parts of this model are fairly well understood.  There is significant understanding 
of how CVD risk factors influence systemic vascular remodeling, and how vascular remodeling 
then is itself a CVD risk factor.  Many studies have described the hemodynamic, hormonal and 
metabolic changes of pregnancy and the remodeling of the utero-placental vasculature.  It is 
understood that inadequate utero-placental vascular remodeling is related to pregnancy 
complications. 
Most parts of the model are not well understood.  There is little understanding of what 
risk factors influence utero-placental vascular remodeling and risk of pregnancy complications.  
Small cross-sectional studies suggest that systemic vascular remodeling in pregnancy may reflect 
the degree of utero-placental vascular remodeling, but much more work is needed to understand 
this relationship.  Only very small prospective studies have described systemic vascular 
remodeling in pregnancy, and these were not done in women reflective of the US population.  
We do not know the extent to which uterine and systemic vasculature return to baseline in the 
postpartum period.  Only cross-sectional studies explore the relationship between pregnancy and 
long-term vascular health. 
A full understanding of these complex relationships requires a life-course approach far 
beyond the scope of a doctoral dissertation.  It would require large cohort studies following 
women from childhood to death, with measurement of risk factors and measures of the 
vasculature at multiple points.  It would require participation from health care providers, 
epidemiologists, and basic scientists. 
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Nonetheless, this dissertation may help elucidate 3 parts of the model, using data from 
two different studies.  The Slow Adverse Vascular Effects (SAVE) clinical trial provided healthy 
overweight and obese young adults with an intensive lifestyle intervention aimed at weight loss 
and explored changes in their vascular measures.  The reproductive ancillary study collected 
reproductive data on women participants in SAVE. Paper 1 explores the relationship between 
parity and remodeling of the carotid artery in women in SAVE, illuminating how pregnancy 
changes may persist post-childbearing.  The Maternal Adaptation to Healthy Pregnancy Study 
(MVP) prospectively assessed CCA IMT, IAD, and brachial artery distensibility, in 43 healthy 
primigravid women throughout pregnancy and postpartum.  Paper 2 analyzes the changes that 
occur in CCA IMT and IAD and Paper 3 the changes in brachial artery distensibility during 
pregnancy.   Both MVP papers address factors that are associated with these structural and 
functional changes including maternal weight, weight gain, and blood pressure, and glucose, 
lipid and C - reactive protein concentrations. 
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1.7 SPECIFIC AIMS 
 
Paper 1:   
Specific aim 1:  To investigate the relationships between reproductive factors and the prevalence 
of subclinical cardiovascular disease in women enrolled in the SAVE study. 
 Hypothesis:  Higher parity will be associated with greater intima-media thickness. 
 
Paper 2: 
Specific aim 1: To prospectively assess common carotid artery adventitial diameter and intima 
media thickness throughout healthy first pregnancy and postpartum.  
Hypotheses: 
• During the course of a normal pregnancy adventitial diameter will increase, followed by 
increase in intima media thickness.   These will return to baseline postpartum. 
• Pre-pregnancy body mass index will be related to increases in common carotid artery 
diameter and intima-media thickness. 
• Increase in weight over the course of the pregnancy will be the primary factor associated 
with increase in common carotid artery diameter and intima media thickness. 
 
Paper 3: 
Specific aim 1: To prospectively assess brachial artery stiffness throughout healthy pregnancy 
and postpartum.  
Hypothesis: The brachial artery will remain elastic throughout the course of pregnancy. 
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Table 1.1 Hemodynamic and Metabolic Changes of 
Healthy Pregnancy 
Hemodynamic Increased cardiac output 
Increased plasma volume 
Increased heart rate 
Decreased systemic vascular 
resistance 
Decreased mean arterial pressure    
(returns to baseline at term) 
Metabolic Increased insulin resistance 
Lower fasting and higher post-
prandial glucose  concentrations 
Increased insulin  concentrations 
Increased lipid concentrations        
(total cholesterol, triglycerides, LDL-
c, HDL-c) 
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CVD is cardiovascular disease.  EVT is extravillous trophoblast cells.  Solid lines represent well-understood pathways.  
Dashed lines represent less well-understood pathways. 
Figure 1.1 Conceptual model relating remodeling of systemic and utero-placental vasculature
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2.1 ABSTRACT 
 
Objective: Higher parity is associated with m subclinical cardiovascular disease (CVD) in mid-
life and older women, and with increased CVD risk overall.  The relationship between parity, 
subclinical CVD, and infertility in overweight and obese young women has been infrequently 
evaluated. 
 
Methods: Reproductive histories were obtained in 191 (73%) overweight and obese (BMI 25 – 
39.9 kg/m2) young women participating in a weight loss trial.  Baseline carotid intima-media 
thickness (IMT) and inter-adventitial diameter (IAD) were assessed via B-mode ultrasound.    
Linear regression was used to estimate the relationship between parity and carotid measures, 
adjusted for demographic, cardiovascular and reproductive risk factors. 
 
Results: Nulliparous women (n=70, age 34.9 ± 7.1) had increased common carotid IAD (.230 
mm, SE .08, P = .006) and mean CCA IMT (.031 mm, SE .01, P = .009) compared with parous 
women (n=102, age 39.5 ± 4.9) after adjustment for age, race, and CVD risk factors.  No other 
reproductive factors were statistically significantly associated. 
 
Conclusions: Nulliparity is associated with markers of less healthy carotid arteries in a sample 
of disease-free, overweight or obese 25-45 year-old women.  This may represent a beneficial 
effect of pregnancy or indicate overall better health in overweight/obese women capable of 
childbearing.   
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 2.2 INTRODUCTION 
 
Nearly two-thirds of US women of childbearing age are at elevated risk for 
cardiovascular disease (CVD) because they are overweight or obese,185 but little is known about 
how reproductive factors influence CVD risk in this population.  Studies demonstrate a 
relationship between parity (number of births after 20 weeks gestation)186 and CVD risk in the 
general population.  A cohort study of more than a million Swedish women demonstrated a J-
shaped relationship, with lowest CVD risk in women with 2 births.   Women of lower parity had 
a 10% increased risk, and women of parity 5+ had a 50% increased risk.77 This population, 
however, is leaner and more homogeneous than the US population.  Understanding the 
relationship between parity and CVD risk in overweight women may lead to better screening and 
interventions to decrease excess risk of high or low parity in this already high risk group. 
Changes in inter-adventitial diameter (IAD) and intima-media thickness (IMT) of the 
carotid arteries serve as markers of vascular aging and can be measured reliably and non-
invasively using high frequency B-mode ultrasound.  Multiple studies have demonstrated that 
increased IAD and thicker IMT are associated with traditional CVD risk factors and ultimately 
with cardiovascular events,26,39  and they are often used as surrogate markers for CVD risk.  
Several investigations have examined the relationship between parity and IMT with inconsistent 
results.  In a prospective study of women of childbearing age, each birth over a 6 year period was 
associated with a 7.5 ± 3.2 µm increase in mean IMT of the common carotid artery (CCA).85    
Cross-sectional studies  have largely shown increased CCA IMT with increased parity in 
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midlife175,176 and younger women;84 one study also showed increased CCA IMT in nulliparous 
women.176 
Thus, increases in CCA IMT with parity may reflect a potential mechanism linking parity 
to CVD, but many questions remain unanswered.  Women in the aforementioned studies were 
relatively lean and not representative of the current US population. They were primarily mid-life 
or older.  The existing studies did not evaluate the effect of infertility on CVD risk, ignoring a 
potentially significant confounding factor.  In the majority of studies, the CCA, not other 
segments of the carotid artery, was assessed.  IMT measured in different segments of the carotid 
artery have different CVD risk factor associations and may reflect varying pathophysiology, thus 
providing further insight into the underlying CVD mechanisms involved.187  Body mass index is 
most closely related to CCA IMT, while glucose metabolism is more related to bulb and ICA 
IMT.187  Furthermore, none of the studies assessed parity’s relationship with IAD, itself an 
independent CVD risk factor and marker of vascular remodeling and aging.7,39 
The purpose of this analysis is to explore the relationship between parity and structure of 
the common and internal carotid arteries and the carotid bulb in a US population of overweight 
or obese women of reproductive age without history of fertility problems.  We hypothesized that 
parity would be positively related to IMT and IAD in the CCA. 
 
2.3 METHODS 
 
2.3.1 SAVE Study Design and Population 
This study is a secondary analysis of data from the Slow Adverse Vascular Effects 
(SAVE) clinical trial (NCT00366990).  Methods for participant recruitment and intervention in 
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the SAVE trial have been previously reported.188  Briefly, SAVE is a randomized controlled trial 
examining effects of weight loss, physical activity, and sodium reduction on vascular health.  
Participants (N = 349) were 25-45 year-old women and men from Allegheny County, PA, who 
were physically inactive and overweight to class II obese (BMI 25 – 39.9).  Exclusions were: 1) 
diabetes; 2) hypertension; 3) current use of cholesterol-lowering, antipsychotic, or vasoactive 
medicines; 4) underlying inflammatory conditions; 5) known atherosclerotic disease; and 6) 
pregnancy or breastfeeding.  No other requirements about reproductive history were included.  
All participants signed an informed consent document approved by the University of Pittsburgh 
Institutional Review Board. SAVE enrolled 290 women between June 2007 and February 2009; 
191 (66%) completed the reproductive history and 19 reported infertility, leaving 172 (59%) 
women for the analytic sample for this study. 
 
2.3.2 Carotid Artery Measures 
Carotid ultrasounds were performed at the University of Pittsburgh Ultrasound Research 
Laboratory (Pittsburgh, PA) using high resolution B-mode ultrasound (Siemans, Malvern, PA).  
This analysis uses the baseline values.  The carotid arteries were imaged bilaterally at end 
diastole with participants supine.  IMT, the distance from the media- adventitial interface to the 
intima-lumen interface, was measured bilaterally in four locations:  the near and far walls of the 
common carotid artery 1 cm proximal to the carotid bulb, the far wall of the carotid bulb, and the 
far wall of the internal carotid artery (ICA) for the first 1 cm distal to the flow divider.   Mean 
and maximum values were calculated for each carotid segment and the mean and maximum of 
the eight readings identified.  Inter-adventitial diameter was measured as the distance from the 
adventitial-medial interface of the near wall of the common carotid artery to the medial -
36 
adventitial interface of the far wall.  Reproducibility of IMT was excellent with an intraclass 
correlation coefficient of ≥0.82 between sonographers and ≥ 0.97 between readers.188  A semi-
automated reading program (AMS system) allowed the reading to be done by computer. 189 
 
2.3.3 Reproductive Histories 
Starting June 1, 2009, all women participants were given reproductive history forms to 
complete.  Studies have demonstrated high reliability and validity for maternal recall of 
pregnancy-related events.190,191 Participants reporting they had ever been pregnant then 
completed a form for each pregnancy.  They designated each birth outcome as a live birth, 
tubal/ectopic pregnancy, abortion, miscarriage (fetus born before 20 weeks or 5 months 
gestation), stillbirth (baby lost after 20 weeks or 5 months gestation) or current pregnancy.  
Parity was calculated as the sum of live (n=257) and stillbirths (n=6).  Women who reported a 
pregnancy since their baseline visit were coded with their parity at baseline. 
Each pregnancy form asked for date of pregnancy outcome, birth weight, length of 
gestation, presence of specific pregnancy complications, and breastfeeding duration.  Women 
were coded as having had any pregnancy complication if they reported a stillbirth, preeclampsia 
or gestational hypertension in any pregnancy, or a birth weight of < 2500 grams or gestational 
age of less than 37 weeks for any singleton pregnancy.  Women were designated as having a 
history of infertility (n=19) if they answered yes to either: “Have you ever had a period of 12 
months when you could not get pregnant although you would have liked to get pregnant” or 
“Have you ever taken any fertility medication to help you get pregnant?”  Women reported usual 
menstrual cycle length and whether they had menstruated in the past 12 months. 
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 2.3.4 Demographic, Physical, and Laboratory Measures 
Participants provided self-reported information at baseline regarding age, gender, race, 
and smoking status.  Staff measured height, weight and blood pressure using standardized 
protocols.  Body mass index (BMI) was calculated as weight in kilograms divided by height in 
meters squared.   
Laboratory assays were performed on fasting serum samples at the Heinz Laboratory at 
the University of Pittsburgh (Pittsburgh, PA).  Total cholesterol, HDL(c), LDL(c), and glucose 
were determined using standard laboratory procedures. 
 
2.3.5 Statistical Analysis 
Normally distributed variables are presented as mean ± SD and categorical variables as 
percentages.  Characteristics of women who did and did not participate in the reproductive study 
were compared.  Due to small numbers of women of high parity (parity 4 n=8, parity 5 n=1), 
women of parity 3 or greater were analyzed together.  As only 5 women reported a race other 
than white or black, women were classified as black or non-black for the analysis.  Because of 
significant difference in age and racial composition of the different groups, age and race-adjusted 
means for the carotid measures were calculated.  When analysis of variance testing detected a 
significant difference among these means pair-wise comparisons were done.  Inspection of these 
results demonstrated that IAD and CCA IMT were greatest in nulliparous women and 
approximately equal in women with parity 1, 2 and 3+ (Figure 1).  For this reason we compared 
nulliparous to parous women for the remaining analyses. 
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Multivariable linear regression was used to estimate the relationship between parity and 
the carotid measures.  Covariates were considered a priori according to known factors associated 
with the carotid measures and CVD, and retained in the model if they were statistically 
significant predictors and affected the parameter estimates for any of the outcomes.  The first 
model was adjusted for age, race, and educational achievement, our chosen measure of 
socioeconomic status.  The second model included adjustment for those demographics plus 
baseline cardiovascular risk factors: BMI, current smoking, use of alcohol, average systolic 
blood pressure, fasting glucose and non-HDL cholesterol concentration.  Educational 
achievement and non-HDL cholesterol concentration did not meet inclusion criteria and were 
dropped from the model to maintain precision.  A third model was considered including all of the 
previous covariates with reproductive factors: menopausal status, regularity of menstrual periods, 
breastfeeding, and the composite variable for pregnancy complications.  None of these met the 
criteria for inclusion in the final model.  Thus, the main model included parity, age, race, BMI, 
current smoking, alcohol use, systolic blood pressure and fasting glucose level.  We explored 
interactions between BMI category (25-29.9, 30-34.9, 35+) and parity and between race and 
parity in this model, and also adjusted the IMT models for IAD. 
A separate analysis was done for parous women to estimate the effects of levels of parity 
(1, 2 or 3+) on carotid measures using the main model as with additional factors unique to parous 
women:  age at first birth and time since last birth.  These factors were not significant predictors 
and results are not presented here. 
A sensitivity analysis to test for potential residual confounding based on infertility history 
considered a model including all women in SAVE to test the effect of known infertility on the 
carotid measures, controlling for parity, demographic and cardiovascular risk factors. 
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All statistical analyses were performed using SAS 9.2 or 9.3 (SAS Institute, Cary, NC) 
with significance level set at p = 0.05. 
 
2.4 RESULTS 
 
Participants and non-participants in the reproductive study were largely comparable at 
baseline (Table 2.4).  Participants had a lower BMI (32.2 vs. 33.7, p = 0.01) and higher total 
(207.2 vs. 193.9, p = 0.01) and LDL (125.2 vs. 116.3, p = 0.03) cholesterol.  For participants, 
average age increased with parity, from 34.9 years old for nulliparas to 40.7 for women of parity 
3+ (Table 2.1).  Black women were over-represented in the group with parity of 1 (46%, vs. ≤ 
14% in the other groups).  Nulliparous women were more likely to regularly consume alcohol.  
By study design all women were overweight or obese, and mean BMI of 32 did not differ 
significantly by parity. 
Among traditional CVD risk factors, only HDL(c) differed by parity and was highest in 
nulliparous women.   Nulliparous women tended to be current smokers compared to women of 
parity 3+ (12.9% vs 0.0%). Average systolic blood pressure, fasting glucose, total cholesterol, 
LDL(c), and triglycerides were similar among all groups.   
For reproductive factors, history of irregular menstrual periods was similar in each group.  
Among parous women, age at first birth and rate of reporting any pregnancy complication were 
similar.  Women of higher parity were more likely to have ever breastfed and to be post-
menopausal, and had a shorter time since their last birth. 
Nulliparous women had the highest values for IAD, average CCA IMT, maximum CCA 
IMT, average IMT and maximum IMT (Table 2.2).  For the 3 measures in the CCA, nulliparous 
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women had the highest values and values for the 3 levels of parity are roughly equivalent.  When 
comparing the adjusted means for nulliparous vs. parous women these results were statistically 
significant (Figure 2.1).  Patterns were less obvious for the other carotid measures.  There was no 
clear pattern for internal carotid artery IMT.  Bulb IMT, however, was significantly greater for 
nulliparous women and for women with 3 or more births than for women with 2 births. 
Relationship between having ever given birth and the carotid measures is presented in 
Table 2.3.  After adjustment for demographics and cardiovascular risk factors nulliparous women 
had IAD 0.20 mm larger (p=0.006), average CCA IMT 0.03 mm thicker (p=0.010) and 
maximum CCA IMT 0.04 mm thicker (p= 0 .004) than parous women.  Average bulb IMT, 
average IMT, and maximum IMT were also greater in nulliparous women, but these differences 
do not reach significance.  There were no differences in average ICA IMT based on parity.  
Adjustment for IAD attenuated the differences in IMT. 
There was no significant interaction between BMI and nulliparity.  In the final model the 
interaction term for black race and parity was statistically significant for mean CCA IMT 
(p=0.01) and borderline significant for maximum CCA IMT (p=0.058).   Figure 2.2 shows that 
black women had thicker mean and maximum CCA IMT than did non-black women, and the 
difference between IMT for nulliparous and parous women appeared greater for blacks than for 
non-blacks. 
In the sensitivity analysis including the 19 women with a known infertility history, 
infertility was not a significant predictor of any carotid outcome, although the effect size was 
similar to the effect size of nulliparity for mean and maximum CCA IMT (Table 2.5). 
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 2.5 DISCUSSION 
 
This analysis demonstrates that in a sample of disease-free overweight and obese young 
women without known infertility history, nulliparity is associated with less healthy markers of 
subclinical CVD even after accounting for traditional CVD risk factors.  Nulliparous women had 
greater IAD and mean and maximum CCA IMT compared to parous women, and thicker bulb 
IMT compared to women with 2 births.  Increased IAD seemed to mediate some, but not all of 
the difference in IMT measures. This might describe a first birth effect – a one-time change 
occurring after first birth but not repeated after subsequent births - as seen with decreased   HDL-
c and systolic blood pressure after a first birth.65,66  Or it may represent the left peak of a J-
shaped relationship, similar to the J-shaped relationship seen between parity and cardiovascular 
risk.  The small number of women of higher parity makes it difficult to discern if CCA IMT or 
IAD might increase with higher numbers of births.   
Our results contradict findings of some studies.  In the Rotterdam Study, among women 
aged 55-99 years old, there was a trend towards increased mean and maximum CCA IMT with 
increased parity, significant even after adjustment for demographics and cardiovascular risk 
factors.175  The Study of Health in Pomerania detected a U-shaped association between CCA 
IMT and parity in women aged 45-79 years old.  After adjustment for demographic, 
cardiovascular risk, and reproductive factors, greatest mean and maximum CCA IMT were in 
women with parity of 0 or 3 or greater.176    Different rates of nulliparity (20% in the Rotterdam 
Study and 8.5% in the Study of Health in Pomerania) may explain the contradiction.  The authors 
of the Pomerania study suggest that in the Rotterdam Study many women were nulliparous by 
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choice, while in their population most nulliparous women had true infertility.  Women with 
infertility may be at higher risk for CVD because of hormonal conditions such as polycystic 
ovary syndrome that can lead to both infertility and increased CVD risk factors.79  Our study 
addressed this issue by removing women with known infertility from the analysis.    
These studies both looked at mid-life and older women, as opposed to the younger 
women in our study.  It is possible that pregnancy has differing effects on vasculature at different 
times.  Our study may show short term positive effects on vasculature from the increased 
hormone levels and cardiac output of pregnancy, while studies in older women may reflect 
negative long-term effects of pregnancy on lipid levels, glucose metabolism, and weight and 
body fat.  Women in these studies were also leaner than women in our analysis, with average 
BMI’s of about 28 and 27, compared to the average BMI of 32 in our study.  This suggests that 
the effects of pregnancy on the vasculature might differ in women who are and are not obese. 
Our results also differ from those of the only study done in women of childbearing age.  
The Cardiovascular Risk in Young Finns Study followed 1005 women aged 24-39 years old for 
6 years and found that mean CCA IMT increased 0.0075 mm for each birth occurring during that 
time period, after adjusting for demographic and cardiovascular risk factors.85   The authors 
speculated this increase may be a result of atherogenic metabolic changes in pregnancy.  The 
women in the studies differ substantially; women in the Young Finns study were substantially 
leaner, with average BMI of about 24.  It is possible that pregnancy has different net effects on 
vascular health depending on women’s risk factor profiles, including BMI.84  
Our finding that carotid bulb IMT is not associated with nulliparity is consistent with the 
findings of Kharazmi et al. They studied 746 Finnish women between the ages of 45 and 74 
years old and found no relationship between parity and the mean of the IMT in the CCA and the 
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carotid bulb, after adjustment for demographic and cardiovascular risk factors.177  We found 
different patterns of change in the CCA and bulb, suggesting they should not be analyzed 
together.  This is supported by various population-based studies that found that bulb IMT is 
related to true atherosclerosis, while CCA IMT is more a marker of vascular aging and 
adaptation.187 
One possible explanation for increased CCA IMT and inter-adventitial diameter in 
nulliparous women is potential residual confounding from fertility status.  While we removed all 
women reporting infertility from the sample, some nulliparous women may have never attempted 
pregnancy and could have unidentified fertility problems.  If these women had greater IMT and 
IAD, the increased values we found in nulliparous women may be from the influence of 
unidentified infertility, not nulliparity. In our model comparing women with and without known 
fertility problems the effect size of infertility was very similar to the effect size of nulliparity for 
mean and maximum CCA IMT.  This suggests that some of the nulliparous women may have 
unknown infertility, and that infertility-related problems may be the cause of the less healthy 
arterial parameters. 
Another possible explanation is that these results represent a beneficial effect of 
pregnancy on the vasculature.  Several studies of midlife women demonstrate that higher levels 
of estrogen are associated with lower IMT and/IAD.100,101,105,106  Perhaps we are seeing a lasting 
positive effect from increased pregnancy hormones assessed an average of 9 years after 
pregnancy. 
Two findings relating to health equity deserve further study.  Lower educational 
attainment was associated with thicker average and maximum IMT after adjustment for age and 
race, but not after adjustment for CVD risk factors.  This suggests that CVD risk factors may 
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mediate a relationship between less education and CVD, and merits thorough exploration in a 
larger study with a more diverse population.  In our study, as in others, 26,192,193 black women had 
worse measures of subclinical CVD than non-black women; our study adds that differences 
between nulliparous and parous women were greater for black women, and indeed, may only be 
present in black women.  This suggests that overweight, black, nulliparous women might 
represent a group at particularly elevated risk for CVD, and should be explored further. 
This analysis is one of the only studies of the relationship between parity and vascular 
health in overweight and obese young women and it uses well-validated, reliable measures of 
IMT and inter-adventitial diameter.  Limitations include small sample size and reliance on self-
report pregnancy histories.  Lack of healthy weight participants makes aspects of the results 
difficult to interpret; a life course epidemiologic study would be necessary to determine the full 
trajectory of the relationship between reproductive events and changes in adiposity and markers 
of vascular remodeling.  The consideration of multiple IMT outcomes may increase the risk of 
Type 1 error, and P-values should be considered in this light.  The study selection criteria are 
both a strength and a limitation.  By including only overweight or obese women who are non-
diabetic and normotensive the study limits the generalizability of the results and also limits its 
ability to determine fully whether pregnancy’s effects on BMI, glucose metabolism, and blood 
pressure mediate pregnancy’s effect on the vasculature.  At the same time, by focusing on a 
uniform group of women, the study is able to limit confounding factors and focus on the effects 
of the pregnancy itself. 
Pregnancy affects cardiovascular health in many ways and the ability to achieve 
successful pregnancy is a marker of good health.  This study demonstrates that nulliparous 
overweight and obese young women show poorer vascular health compared to parous women, as 
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measured by greater CCA IMT and inter-adventitial diameter.  Nulliparous overweight and 
obese women, particularly black women, may be at increased risk for CVD even if they are 
normotensive and non-diabetic, and may particularly benefit from risk reduction efforts. 
46 
2.6 TABLES AND FIGURES 
Table 2.1  Baseline characteristics of participants in SAVE reproductive substudy by parity 
Nulliparous Parity 1 Parity 2 Parity 3+ 
 
Overall 
Nulliparous 
 vs. Parous 
n = 70 n = 26 n = 45 n=31 P Value   P Value  
Age (yr) 34.9 ± 7.1 37.5 ± 6.1 39.8 ± 4.6 40.7 ± 3.8 0.000 <.000 
Black race 10 (14.3) 12 (46.2) 7 (15.6) 5 (16.1) 0.004 0.135 
College graduate 58 (82.9) 14 (53.9) 28 (66.6) 18 (58.0) 0.162 0.014 
Body mass index (kg/m2) 32.5 ± 4.5 32.3 ± 4.1 32.1 ± 3.4 31.8 ± 3.1 0.889 0.550 
Alcohol consumption > 
1/month    
41 (58.6) 9 (34.6) 14 (31.1) 14 (45.2) 0.020 0.004 
Average systolic blood pressure 112.4 ± 9.8 112.6 ± 8.8 112.2 ± 9.9 112.3 ± 9.9 0.999 0.959 
Current smoking 9 (12.9) 3 (11.5) 3 (6.7) 0 (0.0) 0.174 0.112 
Fasting glucose (mg/dl) 97.1 ± 8.7 97.2 ± 8.1 97.2 ± 8.6 97.6 ± 7.3 0.995 0.863 
Total cholesterol (mg/dl) 205.3 ± 38.9 207.1 ± 38.5 198.6 ± 35.7 213.1 ± 42.8 0.452 0.977 
LDL (mg/dl) 118.1 ± 35.8 129.3 ± 36.4 120.9 ± 28.1 133.8 ± 37.4 0.142 0.098 
Triglycerides (mg/dl) 138.8 ± 76.8 116.4 ± 134.6 113.0 ± 60.0 128.7 ± 53.3 0.353 0.110 
HDL (mg/dl) 60.0 ± 15.2 55.1 ± 14.9 55.1 ± 11.4 53.7 ± 11.5 0.091 0.012 
Reproductive History 
 Irregular menses 5 (7.1) 0 (0.0) 2 (4.4) 2 (6.5) 0.552 0.351 
 Post-menopause 4 (5.7) 3 (11.5) 2 (4.4) 7 (22.6) 0.030 0.180 
 Any pregnancy complication - 8 (30.8) 14 (31.1) 13 (41.9) 0.563 
 Ever breastfed - 16 (61.5) 39 (86.7) 26 (83.9) 0.032 
 Age at first birth (yr) - 25.5 ± 5.9 26.2 ± 4.7 24.7 ± 4.5 0.457 
 Time since last birth (yr) - 11.6 ± 6.9 9.0 ± 6.1 7.7 ± 3.6 0.040 
Values shown are means ± SDs or frequency counts (with percentages). 
P values from analysis of variance or chi-square test, as appropriate. 
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Table 2.2 Age and race-adjusted mean carotid measures by parity in women without infertility history  
Nulliparous Parity 1 Parity 2 Parity 3+ 
n = 70 n = 26 n = 45 n = 31 P value 
Carotid Measure (mm) 
Inter-adventitial Diameter 6.942 (.057) 6.794 (.093)  6.657 (.069)*  6.722 (.086)† 0.018 
Average CCA IMT  .610 (.008) .579 (.013)  .579 (.010)  .577 (.012) 0.062 
Maximum CCA IMT .719 (.010) .682 (.016)  .686 (.012)*  .671 (.015)* 0.037 
Average ICA IMT .547 (.016) .575 (.027)  .518 (.020)  .567 (.024) 0.254 
Average bulb IMT .688 (.016) .672 (.025)  .627 (.019)†  .713 (.023)‡ 0.018 
Average IMT  .613 (.009) .601 (.015) .576 (.011) .606 (.014) 0.084 
Maximum IMT .770 (.013) .748 (.021)  .724 (.016) .756 (.019) 0.167 
Values shown are means (standard error). 
* Different from nulliparous at p <.01
† Different from nulliparous at p <.05 
‡ Different from parity 2 at p <.01 
P values from analysis of variance. 
Table 2.3 Carotid measures for parous vs. nulliparous women.  Regression coefficients represent change 
from a baseline parity of 0 
Age & Race adjusted Model 11 Model 22 
Carotid Measure (mm) ß (SE) P value ß (SE) P value ß (SE) P value 
Inter-adventitial 
Diameter 
.230 (.077) .0032 .201 (.073) .0064 - - 
Average CCA IMT -.031 (.011) .0067 -.028 (.011) .0095 -.017 (.010) .0948 
Maximum CCA IMT -.039 (.014) .0050 -.038 (.013) .0036 -.028 (.013) .0298 
Average ICA IMT  .000 (.022) .9889  .003 (.022) .9013 .006 (.022) .7791 
Average bulb IMT -.024 (.021) .2589 -.013 (.021) .5351 -.009 (.021) .6769 
Average IMT .022 (.017) .0801 -.017 (.011) .1422 -.009 (.012) .4292 
Maximum IMT -.030 (.017) .0811 -.025 (.016) .1299 -.018 (.017) .2901 
1Model 1 represents the simultaneous effects of parity, age, race, BMI, current smoking, use of alcohol, average systolic blood 
pressure, and fasting glucose level on the carotid measures. 
2Model 1 with inter-adventitial diameter. 
P values represent significance of regression coefficient for parity. 
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Table 2.4   Comparison of participants and non-participants in reproductive study 
Non-participant Participant 
Characteristic n=79 n=191 P value 
Age (yr)  37.9 ± 6.1  38.0 ± 6.2 0.95 
Black   16 (20.3)  35 (18.3) 0.71 
College graduate  64 (81.0)  134 (70.2) 0.07 
Body mass index (kg/m2)  33.7 ± 3.7  32.2 ± 3.9 0.01 
Alcohol consumption > 1/month  31 (39.2)  87 (45.6) 0.34 
Average systolic blood pressure  112.5 ± 12.2  112.4 ± 9.9 0.95 
Current smoking  7 (8.9)  7 (8.9)  0.99 
Fasting glucose (mg/dl)  97.4 ± 8.1  97.1 ± 8.3 0.81 
Total cholesterol (mg/dl)  193.9 ± 33.9  207.2 ± 39.4 0.01 
LDL (mg/dl)  116.3 ± 28.7  125.2 ± 35.7 0.03 
Triglycerides (mg/dl)  118.6 ± 64.4  129.8 ± 81.4 0.23 
HDL (mg/dl)  54.0 ± 11.4  56.4 ± 14.0 0.14 
Values shown are means ± SD or frequency counts (with percentages). 
P values from analysis of variance or chi-square test, as appropriate. 
Table 2.5  Effect of infertility on common carotid artery measures 
Carotid Measure (mm) ß (SE) P value 
Inter-adventitial diameter  .047 (.11) 0.658 
Average CCA IMT  .027 (.02) 0.092 
Maximum CCA IMT  .024 (.02) 0.201 
Average ICA IMT  .023 (.03) 0.462 
Average bulb IMT  -.005 (.03) 0.872 
Average IMT  .018 (.02) 0.287 
Maximum IMT  .015 (.02) 0.522 
Model represents the simultaneous effects of parity, age, race, BMI, smoking status, use of alcohol, average systolic blood 
pressure and fasting glucose level on the carotid measure.  P value is for regression coefficient for infertility. 
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Figure 2.1 Age and race-adjusted carotid artery measures by parity 
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Figure 2.2 Interaction between race and parity, adjusting for age, body mass  index, 
smoking, alcohol use, systolic blood pressure and fasting glucose levels. P values 
are for race x parity interaction 
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3.1. ABSTRACT 
Objectives:  Higher parity is associated with greater subclinical cardiovascular disease (CVD) in 
mid-life and older women, and with higher risk of CVD overall.  Prospective studies of arterial 
change throughout normal pregnancy are lacking; without them it is unclear whether unhealthy 
changes of the vasculature during pregnancy persist postpartum and raise women’s risk of CVD. 
The goal of this study was to prospectively assess normal vascular adaptation in healthy pregnant 
women.  Our hypotheses were that during the course of healthy pregnancy:  1. CCA inter-
adventitial diameter (IAD) will increase, then return to baseline postpartum, and 2. CCA IMT 
will initially thin, then thicken as pregnancy progresses, and return to baseline postpartum. 
Methods:  The Maternal Vascular Adaptations to Healthy Pregnancy Study (Pittsburgh, PA, 
2010-2013) assessed 43 healthy women during each trimester of their first pregnancy and 6-8 
weeks postpartum at which time points B-mode ultrasound imaging measures of CCA IMT and 
IAD, independent predictors of CVD risk, were obtained. Linear mixed models were used to 
compare measures of CCA IMT and inter-adventitial diameter at each time point, after 
adjustment for age and pre-pregnancy body mass index.  Various physical and cardiometabolic 
measures were then considered as mediators of the relationship between pregnancy and carotid 
measures. 
Results:  There were 37 women (age 28.2 ± 4.5 years, pre-pregnant BMI 24.4 ± 3.2 kg/m2) with 
uncomplicated pregnancies.  After adjustment for age and pre-pregnancy BMI, mean (SE) CCA 
IAD (mm) increased each trimester, from 6.38(0.08) in the 1st trimester to 6.92(0.09) in the 3rd 
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trimester, and returned to first trimester levels, 6.35 (0.07), postpartum.  Mean (SE) CCA IMT 
(mm) was increased postpartum (0.567 (0.01)) compared to 1st (0.539 (0.01)) and 2nd trimester 
values (0.546 (0.01), p < .05 for each).  In multivariable models, higher systolic blood pressure 
and lower insulin resistance and C-reactive protein were associated with greater CCA IMT, but 
did not explain the change occurring during the pregnancy cycle. 
 
Conclusions:  As hypothesized, in uncomplicated first pregnancies CCA IAD increased 
throughout and returned to first trimester levels postpartum.  However, contrary to our 
hypotheses, CCA IMT was increased postpartum.  In uncomplicated first pregnancies, some 
vascular changes resolved (IAD) and others persisted (CCA IMT).  Atherogenic metabolic 
changes of pregnancy did not fully explain the increase in CCA IMT.  Whether this indicates that 
persistence of specific vascular effects of pregnancy may inform long term CVD risk remains to 
be explored. 
 
3.2 INTRODUCTION 
 
Higher parity (number of births) is related to higher cardiovascular disease (CVD) risk in 
women, but the reason for this increase in unknown.75-78  One posited explanation is that the 
increased weight and atherogenic metabolic changes of pregnancy create unhealthy structural 
changes in the systemic vasculature that persist long term.85,174  Studies that might illuminate this 
relationship have been limited by inadequate sample size to detect significant differences in 
vessel parameters,171,194 lack of collection of serial measures of vessel parameters throughout 
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pregnancy,85 use of non-standard techniques to assess the vasculature,173,174 and lack of 
biomarker collection throughout pregnancy.85,171,173,174,194 
B-mode ultrasonography of the carotid artery, a non-invasive, reproducible technique to 
assess arterial structure,17  can be used to assess structural arterial changes (remodeling) during 
pregnancy.  Both greater intima-media thickness (IMT) and inter-adventitial diameter (IAD) of 
the common carotid artery (CCA) are associated with higher cardiovascular disease risk factor 
burden,25-27 arterial aging,21 and higher incidence of cardiovascular disease.26,39  The normal 
changes that occur in the CCA IMT and IAD during a healthy pregnancy have not been well-
established. 
The primary objective of this study was to evaluate prospectively the normal course of 
CCA remodeling measured three times during an uncomplicated first pregnancy and the 
immediate postpartum period (6-8 weeks).   This will illuminate whether normal pregnancies 
result in unhealthy vascular structural change.  A secondary objective was to explore the 
relationship between pre-conception and pregnancy-related physical and metabolic factors and 
arterial adaptation.  We hypothesized: 1) that IAD would increase early in pregnancy to 
accommodate increased blood flow and continue greater through the duration of pregnancy; 2) 
that IMT would initially thin, followed by a thickening later in pregnancy; 3) that pre-pregnancy 
body mass index and increase in weight will be related to increases in IAD and IMT; and 4) that 
the higher concentrations of lipids, insulin resistance, and c-reactive protein known to occur in 
pregnancy would help explain pregnancy’s effects on the vasculature. 
 
 
 
55 
  
3.3 METHODS 
 
3.3.1 MVP Study Design and Population 
The Maternal Vascular Adaptation to Healthy Pregnancy (MVP) study prospectively 
assessed common carotid artery parameters in a cohort of healthy women experiencing their first 
pregnancies.  Recruitment consisted of mailings and flyers distributed to the University of 
Pittsburgh community, use of university research registries, and advertisements in the offices of 
local (Pittsburgh, PA) prenatal care providers and on the internet.  Eligible participants were 
healthy non-smoking women, age 14–40 years, at less than 38 weeks gestational age in their first 
pregnancies.  Exclusion criteria were:  1) vasoactive medication use; 2) infertility history, 
defined as ever having had a period of at least 12 months of inability to achieve pregnancy, or 
using fertility medications to achieve pregnancy; 3) family history of premature coronary artery 
disease; 4) previous abortion; and 5) multiple gestation.  All participants signed an informed 
consent document approved by the University of Pittsburgh Institutional Review Board. 
Study visits were scheduled at 12-14 weeks, 24-26 and 36-38 weeks of pregnancy, and 
then at 6-8 week postpartum.  After a telephone screening for eligibility, women could begin the 
study at any one of the pregnancy visits.  Each visit included physical measures performed by 
research staff and ultrasound measures of carotid parameters.  Visits were conducted between 
June 2010 and March 2013.  The recruitment goal was 46 women; this was based on a 
calculation that 31 women were needed in order to have 80% power to detect a 0.5 SD difference 
for change CCA IMT and IAD given an assumed 0.5 correlation among the repeated 
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observations.  It was assumed that 10-20% of women would develop a pregnancy complication 
and that there would be 25% attrition from the study.  Thus, 46 women were targeted in order to 
obtain 31 women with healthy pregnancies who completed the study.  The study enrolled 44 
women, of whom 43 had multiple visits and 6 developed pregnancy complications, leaving 37 
women in the analytic sample for this analysis. 
 
3.3.2 Carotid Artery Measures 
Carotid ultrasounds were performed by the same 2 research sonographers from the 
University of Pittsburgh Ultrasound Research Laboratory (URL) either at the URL or at the 
Magee-Womens Hospital Clinical and Translational Research Center.  Participants were placed 
supine, with a right hip wedge for comfort if necessary, and the common carotid artery was 
visualized at end diastole with high-resolution B-mode ultrasound (ACUSON Cypress System.)  
The common carotid artery was visualized bilaterally for 1 cm proximal to the carotid bulb, and 
IMT measured as the distance from the media-adventitial interface to the intima-lumen interface.  
Approximately 140 images were digitally recorded for each location.  IMT reported represents 
the mean value for near and far wall bilaterally.  IAD was measured as distance from the 
adventitial-medial interface of the near wall to the media-adventitial interface of the far wall.  
Reading of images was done by computer by one reader, using a semi-automated reading 
program (AMS) system.189  Reproducibility of carotid measures at the URL was excellent during 
the time period of the study, with an intraclass correlation coefficient within the reader of > 0.91 
for CCA IMT and >0.99 for IAD.   
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3.3.3 Demographic, Pregnancy History, Physical and Laboratory Measures 
At the initial visit women completed a self-administered demographic form with 
information on age, race/ethnicity, marital status, education, employment, income, insurance 
status and intended birth site.  Height was measured without shoes using a stadiometer, and the 
mean of 2 readings from the first visit used.   Research staff weighed lightly clothed participants 
on a standard balance scale, and the mean of 2 readings used.  Pre-pregnancy weight was 
identified preferentially as the pre-pregnancy weight documented in the prenatal record or, if not 
available, as a documented weight in the medical record in the three months prior to the last 
menstrual period.  Pre-pregnancy body mass index (BMI) was calculated as pre-pregnancy 
weight in kilograms divided by height in meters squared.  Weight change was calculated as the 
difference between current and pre-pregnancy weight.  Prenatal and birth records were reviewed 
after the final study visit to confirm normalcy of pregnancy and birth and to obtain birth outcome 
information for future analysis. 
After participants rested for 5 minutes in a quiet room, research staff palpated the right 
radial pulse for 30 seconds and then measured blood pressure in that arm using a mercury 
sphygmomanometer according to a standardized protocol.  Three measurements of each were 
taken, and the mean of the last 2 used for the analysis.  Data on demographic and physical 
measures  and from records reviews were collected and managed using REDCap electronic data 
capture tools hosted at the University of Pittsburgh.195   REDCap (Research Electronic Data 
Capture) is a secure, web-based application designed to support data capture for research studies, 
providing 1) an intuitive interface for validated data entry; 2) audit trails for tracking data 
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manipulation and export procedures; 3) automated export procedures for seamless data 
downloads to common statistical packages; and 4) procedures for importing data from external 
sources. 
Laboratory assays were performed on fasting serum samples at the Heinz Nutrition 
Laboratory at the University of Pittsburgh Graduate School of Public Health (Pittsburgh, PA).  
Total cholesterol,196 high density lipoprotein (HDL-c),197 low density lipoprotein (LDL-c)198, 
triglycerides199 and glucose200 were determined using standard laboratory procedures. Insulin 
was measured using standard radio-immune assay (Linco Research, St. Charles, MO). HOMA-
IR, a measure of insulin resistance, was calculated as (glucose x insulin)/405. 201  High-
sensitivity C-reactive protein (hsCRP) was measured with an enzyme-linked immunoassay 
(Alpha Diagnostics International, Inc. San Antonio, TX).   
 
3.3.4 Statistical Analysis 
Distributions were assessed for all variables.  Measures with approximately normal 
distributions were evaluated as means ± standard deviations, measures not normally-distributed 
(hsCRP and HOMA-IR) were analyzed as medians with interquartile range and log-transformed 
to meet model assumptions for the analysis, and categorical variables were presented as 
percentages.  Values for measures that were collected over time (CCA IMT, IAD, physical, and 
laboratory measures) were presented for each of the 4 time points in the study.  Linear mixed 
models with random intercepts and Toeplitz variance and covariance structure were used to 
estimate means for CCA IMT and IAD, adjusted for maternal age and pre-pregnancy BMI, each 
trimester and postpartum; to determine the overall effect of time in the pregnancy cycle on these 
carotid measures; and to determine which specific time points (trimester, postpartum) varied 
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from each other.  The mixed models accounted for differing numbers of study visits by 
participants.   
To determine associations between physical and carotid measures, separate models were 
constructed including systolic blood pressure, weight, and weight change individually with the 
effect of time.  Maternal age and pre-pregnancy BMI were a priori included in all models.  
Predictors with a significance level of P ≤ 0.2 were then placed into models together, and 
predictors with a significance level of P ≤ 0.1 were retained.  Next, to assess our fourth aim, 
biomarkers were tested individually in the best models identified for each outcome.  These were 
also considered potential mediators.  Biomarkers with a significance level of P ≤ 0.1 were then 
placed into the best models together, and significant values retained.  A sensitivity analysis was 
performed eliminating 3 extreme outlier values for hsCRP (≥60 mg/L).  To assess whether 
carotid measures changed over the course of the postpartum period, simple linear regression was 
performed using weeks postpartum as a continuous predictor of CCA IMT and IAD.  P values ≤ 
0.05 were considered statistically significant results for the analysis.  As a sensitivity analysis, 
the analysis was repeated using only data from the 15 women who completed all 4 visits. 
All statistical analyses were performed using SAS statistical software release 9.3 (SAS 
Institute, Cary, NC). 
 
3.4 RESULTS 
 
The mean number of study visits was 3.3 (range 2-4), with 15 women completing all 4 
visits.  At baseline their average age was 28.4 ± 4.6 years and average pre-pregnancy BMI was 
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24.3 ± 3.3.  They were predominantly white (91.9%), married or living as married (89.2%), well-
educated (89.1% college graduate or greater) and employed (64.9% full time, 24.3% part time).    
Inter-adventitial diameter increased throughout pregnancy from a mean (SE) of 6.47 (.12) 
mm in the first trimester to 6.89 (.10) mm in the third trimester (all p< 0.05), then returned to 
early pregnancy measurement by the postpartum visit (6.36 (.07) mm, p= 0.76) (Table 3.1).  
Adjustment for maternal age and pre-pregnancy BMI minimally affected these estimates (Figure 
3.1).  CCA IMT was stable between the first and second trimesters then increased through 
postpartum (first trimester mean (SE) 0.547 (.02) mm, postpartum 0.565 (.01) mm, p= 0.018).  
These values changed minimally with adjustment for maternal age and pre-pregnancy BMI 
(Figure 3.2). 
Changes in weight, blood pressure, heart rate, cardiac output, and lipid, glucose and 
hsCRP concentrations followed expected patterns for healthy pregnancies (Table 3.1).  We 
explored whether weight gain, metabolic and inflammatory markers may explain changes seen in 
IAD and CCA IMT.  Greater weight during pregnancy and postpartum was marginally 
associated with greater IAD and attenuated the increase in IAD that occurred throughout 
pregnancy (Table 3.4).  When metabolic factors were considered as well, higher triglyceride 
concentrations were significantly associated with lower IAD, and higher hsCRP was 
significantly associated with greater IAD (Table 3.2).  Weight was no longer significantly 
associated with IAD.  When postpartum IAD was examined alone, the amount of time passed 
since birth did not significantly predict IAD (Table 3.8). At the postpartum visit, 88% of women 
were fully breastfeeding their infants. 
Higher SBP was significantly associated with greater IMT, but accounting for SBP did 
not attenuate the postpartum increase in IMT (Table 3.3).  Current weight and pre-pregnancy 
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BMI were not significantly associated with IMT (Table 3.5).  When metabolic factors were 
considered as well, greater HOMA-IR was associated with lower IMT values (Table 3.7). 
Accounting for HOMA-IR did not affect the increased IMT observed postpartum (Table3.3).    
When postpartum IMT was examined alone, time passed since birth did not significantly predict 
IMT (Table 3.8). 
All study results were consistent with those from the sensitivity analysis including only 
the 15 women who completed all 4 study visits (data not shown). 
 
3.5 DISCUSSION 
 
This study evaluated the normal course of common carotid artery remodeling that occurs 
during a healthy first pregnancy and determined that, in agreement with our hypothesis, inter-
adventitial diameter of the common carotid artery increased throughout healthy first pregnancy 
and decreased to baseline postpartum.  CCA IMT thickened late in pregnancy and remained 
thickened into the early postpartum period.  Postpartum CCA IMT was greater than the 1st and 
2nd trimester values, and no initial thinning of CCA IMT was observed.  This was contrary to our 
hypothesis that IMT would initially thin, then increase. Our results resemble the patterns 
described in the 2 studies of the topic to date,171,194 and with more participants than those 2 
studies combined our study establishes the statistical significance of those changes. 
These basic patterns agree with what is known about hemodynamic changes in pregnancy 
and the effect of hemodynamic changes on arteries.  Arterial walls attempt to maintain 
homeostasis between the two main stresses from blood flow: shear and tensile stress.  Shear 
stress is the tangential or frictional force of blood flowing along the intima of the artery.  The 
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adaptive response to shear stress is for the diameter of the blood vessel to increase.7,8,86  Cardiac 
output increases early in the first trimester of pregnancy88 peaking at 30-60% above the non-
pregnant level in the late 2nd or early 3rd trimester.88   It would be expected that, as we 
demonstrated, IAD would increase as cardiac output increases.  Tensile stress is the force of 
blood perpendicular to the wall of the artery, and increases as arterial diameter increases.  The 
adaptive response to tensile stress is for the wall thickness to increase.7,87  Thus, as we found, it 
would be expected that IMT would increase during pregnancy as IAD increases, to normalize 
stresses on the arterial wall.23  
Our exploratory analysis suggests that neither baseline characteristics of women nor 
changes in weight fully explained the changes in IAD and CCA IMT that occurred with 
pregnancy.  Triglyceride and hsCRP levels explained some of the changes in IAD, and blood 
pressure and insulin resistance explained some of the changes in IMT. Neither maternal age nor 
pre-pregnancy BMI was associated with IAD; older maternal age was not associated with thicker 
CCA IMT when considered with blood pressure and weight.  The increased weight of pregnancy 
was marginally associated with the increase that occurs in IAD, and may have served as a 
surrogate for the increased blood volume.  As in non-pregnant adults,24 greater systolic blood 
pressure was associated with thicker CCA IMT.  This represents an adaptive response to the 
greater tensile stress on the artery.   
While our study found metabolic changes in pregnancy that may generally be considered 
atherogenic in non-pregnant adults (increased total cholesterol, LDL-c, triglycerides, HOMA-IR 
and hsCRP), these changes did not fully explain the increased IAD and CCA IMT that occurred 
during the pregnancy cycle, and normally occur during healthy pregnancies.  As might be 
expected, higher hsCRP was associated that with greater IAD.  Higher hsCRP concentrations are 
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associated with greater carotid IMT,202-204  and thus may be associated with the related IAD as 
well.  Findings that higher triglyceride concentrations were associated with smaller IAD27 and 
that greater insulin resistance was associated with thinner IMT205 were unexpected, as these are 
different relationships than those found in non-pregnant adults.   Paradigms of CVD prediction 
may not be applicable to the wellness state of pregnancy because of the relatively short 
timeframe of pregnancy and the dramatic changes in weight, blood volume, and hormonal milieu 
that occur. 
Our finding that CCA IMT was increased postpartum could potentially help explain the 
increase in CVD risk that occurs in women of higher parity.75,77    Greater IMT is a risk factor for 
CVD because thickened arteries are less capable of responding effectively to changes in blood 
pressure23 and are more prone to the development of atherosclerosis.13 Several studies have 
identified greater IMT in women of higher parity,84,85,175,176 but it is unknown if the increase is 
caused by persistence of acute changes of pregnancy or by accumulation of CVD risk factors that 
occurs with more pregnancies, or is explained by socio-economic differences between women of 
higher and lower parity. Our study suggests that an acute pregnancy change, thickened CCA 
IMT, may contribute to higher CVD risk, but that atherogenic metabolic changes in pregnancy 
do not appear to be the cause. 
Potentially, findings from our study may provide important baseline information for 
future research about pregnancy complications such as preeclampsia.  Preeclampsia is a 
pregnancy-specific disease defined by new origin hypertension and proteinuria occurring after 20 
weeks of pregnancy.  It complicates 2-8% of pregnancies55 and contributes to 12% of growth 
restricted and up to 20% of preterm infants as well as to 50,000 maternal deaths annually.57  
Cross-sectional studies have found greater CCA IMT in women with pregnancies complicated 
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preeclampsia than in women with normal pregnancies both at term162 and postpartum.156,157  Our 
study provides baseline data that can be used by future prospective studies to help determine 
when arterial change in pregnancies suffering from preeclampsia deviates from the normal 
pattern.  This may lead to better understanding of the pathophysiology of the disease as well as 
possible means for early prediction. 
This study benefits from use of a highly valid and reproducible measure of carotid 
structure and from high retention of participants.  Although we had serial measure during and 
after pregnancy, a key limitation of the study is the lack of pre-pregnancy measures.  The first 
visit was scheduled at 12-14 weeks of pregnancy.  Significant hemodynamic changes of 
pregnancy begin as early as 5 weeks of gestation88 so it is likely that our first trimester values do 
not represent a true pre-pregnancy baseline.  Thinning of the IMT may have occurred before we 
were able to assess it.  The postpartum visit was performed at an average of 8 weeks postpartum.  
It is likely that not all of the hemodynamic changes of pregnancy have resolved at that point90 
and longer follow-up is required to determine if the increased CCA IMT persists.  Participants 
were overwhelmingly breastfeeding at that point, and the results might not reflect those in 
women formula feeding their infants.  The largely white, well-educated women in this cohort 
may not be representative of the general population of first time pregnant women, yet the study 
has utility as providing baseline data against which arterial remodeling in other demographic 
groups can be assessed.  The power calculations for the study were based on the assumption that 
women would attend all 4 study visits; in actuality, women attended an average of 3.3 visits, 
decreasing the power of the study.  However, the correlation between repeated measures was 
higher than that posited, and the difference in IAD was greater, providing sufficient power to 
detect significant differences.  The sensitivity analysis including only the 15 women completing 
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all visits replicated all findings, confirming that failure to attend all the study visits did not 
negatively affect the results. 
We found that IAD increases throughout healthy first pregnancy and decreases by 8 
weeks postpartum. In contrast, postpartum CCA IMT is greater than first trimester values.  These 
adaptations were not well explained by pregnancy-related changes in physical and 
cardiometabolic measures such as weight, blood pressure, lipids, and measures of inflammation 
and glucose metabolism.  Pregnancy may represent a unique system of acute physiologic 
changes that maintain homeostasis during a time of acute stress.  Further studies can use the data 
presented here as a baseline against which to assess differences in maternal vascular adaptation 
among women of different races, obese women, and women experiencing pregnancy 
complications.  Understanding normal adaptation may allow for better understanding of the 
physiology of pregnancy complications and identify women at risk for complications early in 
pregnancy.  If the thickened CCA IMT detected in the immediate postpartum period persists, it 
may help explain the higher CVD risk in women of higher parity. 
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3.6 TABLES AND FIGURES 
 
 
Table 3.1  Unadjusted values for outcomes and key time-varying covariates by trimester 
 
      
 1st Trimester 
         n=15 
2nd Trimester 
n=32 
3rd Trimester 
n=37 
Postpartum 
n=35 
Overall 
P Value 
 
Inter-adventitial diameter (mm) 
 
 6.47 (0.12) 
  
6.79 (0.08) 
  
6.89 (0.10) 
  
6.36 (0.07) 
 
<0.0001 
CCA intima-media thickness (mm) 0.547 (0.02) 0.546 (0.01) 0.553 (0.01) 0.565 (0.01) 0.04 
Weight (kg)  68.7 (2.2) 73.1 (1.6)  79.5 (1.8)   69.2 (1.5) <0.0001 
Weight change (kg)  0.55 (0.46)  7.27 (0.62)  14.4 (0.91)     4.3 (0.75) <0.0001 
Systolic blood pressure (mm Hg) 103.7 (2.1) 106.0 (1.7) 110.4 (1.4) 106.2 (1.7) 0.0005 
Cardiac output (L/min)  5.24 (0.25)  5.71 (0.23)   6.23 (0.23)   4.46 (0.10) <0.0001 
Heart rate (bpm)  78.0 (2.4)  79.8 (1.6)   82.0 (1.5)    68.1 (1.5) <0.0001 
Total cholesterol (mg/dl) 201.7 (8.9) 257.3 (7.0) 273.1 (7.2)  191.4 (5.5) <0.0001 
LDL-c (mg/dl) 111.2 (7.0) 148.0 (6.3) 155.5 (6.6)  114.7 (4.8) <0.0001 
Triglycerides (mg/dl) 108.3 (10.5) 176.5 (10.2) 250.7 (13.6)    77.3 (7.0) <0.0001 
HDL-c (mg/dl)   68.8 (2.2)   74.0 (3.1)   66.8 (2.3)    61.2 (1.8) <0.0001 
Glucose (mg/dl)   79.3 (1.5)   77.2 (1.1)   77.0 (1.2)    82.6 (1.2)   0.0007 
Insulin (µU/ml)   8.84 (0.78) 11.25 (0.98) 11.95 (0.81)    8.59 (0.50)   0.0001 
HOMA-IR 1.64 [1.32, 2.09] 2.16 [1.56, 2.56] 2.28 [1.67, 2.51] 1.77 [1.34, 2.13]   0.01 
hsCRP  (mg/L) 3.58 [2.16, 5.57] 3.36 [2.31, 5.49] 3.29 [2.24, 7.01] 1.20 [.77, 2.44] <0.0001 
      
 
Normally distributed values presented as mean (SE) and P value from analysis of variance. 
Skewed values presented as median [IQR] and P-value from Wilcoxon rank-sum test. 
 
CCA is common carotid artery.  Weight change is change from pre-pregnancy weight. 
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Table 3.2  Association between covariates and inter-adventitial diameter 
 
 
 
 
Unadjusted 
 
Adjusted for age & pre-
pregnancy BMI 
 
Adjusted for age, pre-
pregnancy BMI & weight 
 
Adjusted for age, pre-
pregnancy BMI, weight, 
triglycerides, Log hsCRP 
 
 Β (SE) P value Β (SE) P value Β (SE) P value Β (SE) P value 
Trimester 1   Ref    Ref     Ref     Ref  
Trimester 2  .361 (.07)*‡ .0001  .361 (.07)*‡ <.0001  .294 (.09)*‡ .001  .456 (.07)*‡ <.0001 
Trimester 3  .498 (.07)*† ‡ .0001  .499 (.07)*†‡ <.0001  .338 (.13)*‡ .009  .683 (.12)*†‡ <.0001 
Postpartum -.015 (.05)      .74 -.014 (.05)    .76 -.032 (.05) .49 -.029 (.04)    .44 
Age (yr)   -.004 (.02)    .81  .004 (.02) .82 -.006 (.02)    .73 
Pre-pregnancy BMI (kg/m2)     .046 (.02)   .06  .013 (.03) .67  .006 (.03)    .85 
Weight (kg)      .015 (.01) .08  .011 (.01)    .12 
Triglycerides (mg/dl)       -.002 (.00) <.0001 
Log hsCRP (mg/L)        .070 (.02)   .0002 
 
 
*Different from first trimester at p<.01. †Different from second trimester at p<.05. ‡Different from postpartum at p <.01. 
BMI is body mass index. 
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Table 3.3  Association between covariates and common carotid artery intima-media thickness 
 
  
Unadjusted 
 
Adjusted for age, pre-
pregnancy BMI 
 
Adjusted for age, pre-
pregnancy BMI, SBP & 
Weight Change 
 
Adjusted for age, pre-
pregnancy BMI, SBP, 
Weight Change & HOMA 
 
 Β (SE) P value    Β (SE) P value   Β (SE) P value   Β (SE) P value 
Trimester 1   Ref      Ref     Ref     Ref  
Trimester 2 .001 (.01) .89   .001 (.01) .89 .018 (.01) .17 .017 (.01) .21 
Trimester 3 .013 (.01) .24   .013 (.01) .24 .041 (.02)*† .046 .043 (.02)*† .04 
Postpartum .027 (.01)*† .02   .027 (.01) *† .02 .035 (.01)* .005 .027 (.01)* .03 
Age (yr)     .004 (.00) .03 .003 (.00) .07 .002 (.00) .15 
Pre-pregnancy BMI (kg/m2)   -.001 (.00) .78 -.002 (.00) .35 -.001 (.00) .71 
SBP (mm Hg)     .001 (.00) .04 .001 (.00) .02 
Weight change (kg)     -.002 (.00) .07 -.002 (.00) .07 
Log HOMA-IR       -.029 (.01) .02 
 
 
*Different from first trimester at p<.05. †Different from second trimester at p <.05. 
BMI is body mass index.  SBP is systolic blood pressure. 
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Table 3.4:  Adventitial diameter models adjusted for age and pre-pregnancy BMI with individual physical predictors 
 
  
Unadjusted 
 
Adjusted for age & pre-
pregnancy BMI 
 
Adjusted for age, pre-
pregnancy BMI, & SBP 
 
Adjusted for age, pre-
pregnancy BMI, & wt 
 
Adjusted for age, pre-
pregnancy BMI, & wt 
change 
 
 Β (SE) P value Β (SE) P value Β (SE) P value Β (SE) P value Β (SE) P value 
Trimester 1 Ref  Ref  Ref  Ref  Ref   .84 
Trimester 2 .361 (.07)*‡   .0001 .361 (.07)*‡ <.0001  .389 (.07)* ‡ <.001  .294 (.09)*‡ .001  .321 (.09)*‡ <.001 
Trimester 3 .498 (.07)*† ‡ <.0001 .499 (.07)*†‡ <.0001  .511 (.07)* ‡ <.001  .338 (.13)*‡ .009  .392 (.14)*‡   .008 
Postpartum -.015 (.05)   .74 -.014 (.05)   .76  .010 (.04)   .81 -.032 (.05) .49 -.020 (.05)   .69 
Age (years)   -.004 (.02)   .81 -.003 (.02)   .83  .004 (.02) .82 -.001 (.02)   .93 
Pre-pregnancy BMI (kg/m2)    .046 (.02)   .06  .042 (.02)   .09  .013 (.03) .67  .047 (.02)   .06 
SBP (mm Hg)      .004 (.00)   .29     
Weight (kg)        .015 (.01) .08   
Weight change (kg)         .010 (.01)   .29 
 
 
*Different from first trimester at p<.01. †Different from second trimester at p<.05. ‡Different from postpartum at p <.01. 
SBP is systolic blood pressure.  Weight change is from pre-pregnancy weight. 
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Table 3.5:  Common carotid artery intima-media thickness models adjusted for age and pre-pregnancy BMI with individual physical predictors 
 
 Unadjusted Adjusted for age, pre-pregnancy BMI 
Adjusted for age, pre-
pregnancy BMI, & SBP  
Adjusted for age, pre-
pregnancy BMI, & 
weight 
Adjusted for age, pre-
pregnancy BMI, & weight 
change 
 β(SE) P value Β (SE) P value Β (SE) P value Β (SE) P value Β (SE) P value 
Trimester 1 Ref  Ref   Ref  Ref  Ref  
Trimester 2 .001 (.01) .89 .001 (.01) .89 .002 (.01) .85 .007 (.01) .56 .016 (.01) .19 
Trimester 3 .013 (.01) .24 .013 (.01) .24 .009 (.01) .43 .022 (.02) .22 .042 (.02)*† .04 
Postpartum .027 (.01)*† .02 .027 (.01) *† .02 .026 (.01)*†‡ .03 .031 (.01)*† .01 .036 (.01)* .003 
Age (years)   .004 (.00) .03 .004 (.00) .02 .003 (.00) .08 .002 (.00) .11 
Pre-pregnancy BMI (kg/m2)   -.001 (.00) .78 -.002 (.00) .45 .000 (.00) .93 -.001 (.00) .70 
SBP (mm Hg)     .001 (.00) .08     
Weight (kg)       -.000 (.00) .66   
Weight change (kg) 
         -.002 (.00) .13 
 
*Different from first trimester at p<.05. †Different from second trimester at p <.05. ‡ Different from third trimester at p <.05. 
BMI is body mass index. SBP is systolic blood pressure.  Weight change is from pre-pregnancy weight. 
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Table 3.6:  Adventitial diameter models adjusted for age, pre-pregnancy BMI, weight and individual biomarkers 
 
 Adjusted for age, pre-
pregnancy BMI & weight 
Adjusted for age, pre-
pregnancy BMI, weight & 
total cholesterol 
Adjusted for age, pre-
pregnancy BMI, weight & 
HDL-c 
Adjusted for age, pre-
pregnancy BMI, weight 
& Triglycerides 
Adjusted for age, pre-
pregnancy BMI, 
weight & LDL-c  
 Β (SE) P value Β (SE) P value Β (SE) P value Β (SE) P value Β (SE) P value 
Trimester 1 Ref  Ref  Ref  Ref  Ref  
Trimester 2  .294 (.09)*‡ .001  .406 (.11)*‡ <.001  .307 (.09)*‡ <.001  .412 (.08)*‡ <.001   .359 (.10) <.001 
Trimester 3  .338 (.13)*‡ .009  .474 (.15)*‡   .002  .354 (.12)*‡   .006  .604 (.13)*†‡ <.001   .405 (.13)   .004 
Postpartum -.032 (.05) .49 -.044 (.05)   .34 -.030 (.05)    .55 -.091 (.04)¥   .045 -.031 (.05)   .52 
Age (years)  .004 (.02) .82  .003 (.02)   .85  .002 (.02)   .92 -.005 (.02)   .76   .003 (.02)   .86 
Pre-pregnancy BMI (kg/m2)  .013 (.03) .67  .020 (.03)   .51  .018 (.03)   .56  .009 (.03)   .75   .019 (.03)   .54 
Weight (kg)  .015 (.01) .08  .011 (.01)   .19  .012 (.01)   .14  .011 (.01)   .13   .012 (.01)   .16 
Total cholesterol (mg/dl)   -.001 (.00)   .18       
HDL-c (mg/dl)      .002 (.00)   .52     
Triglycerides (mg/dl)       -.001 (.00)   .005   
LDL-c (mg/dl)         -.001 (.00)   .38 
 
 
Adjusted for age,  pre-
pregnancy BMI, & weight 
Adjusted for age, pre-
pregnancy BMI, weight &  
hsCRP 
Adjusted for age, pre-
pregnancy BMI, weight & 
fasting insulin 
Adjusted for age, pre-
pregnancy BMI, 
weight & fasting 
glucose 
Adjusted for age, pre-
pregnancy BMI, weight 
& Log HOMA-IR 
 Β (SE) P value Β (SE) P value Β (SE) P value Β (SE) P value Β (SE) P value 
Trimester 1 Ref  Ref  Ref  Ref  Ref  
Trimester 2  .294 (.09)*‡ .001  .315 (.08) *‡ <.001  .321(.07)*‡ <.001 .308 (.07) *‡ <.001 .319 (.07)*‡ <.001 
Trimester 3  .338 (.13)*‡ .009  .332 (.12) *‡   .007  .395(.11)*‡ <.001 .380 (.11) *‡ <.001 .388 (.11)*‡ <.001 
Postpartum -.032 (.05) .49 -.022 (.04)   .61 -.043 (.05)   .34 -.034 (.05)   .45 -.051 (.05)   .27 
Age (years)  .004 (.02) .82  .004 (.02)   .84 -.003(.02)   .83 -.003 (.02)   .86 -.003(.03)   .93 
Pre-pregnancy BMI (kg/m2)  .013 (.03) .67  .011 (.03)   .72  .003 (.03)   .91 .036 (.02)   .12 .003 (.03)   .93 
Weight (kg)  .015 (.01) .08  .014 (.00)   .08  .012 (.01)   .11 .013 (.01)   .07 .014 (.01)   .08 
hsCRP (mg/L)    .004 (.00)   .03       
Fasting insulin (µU/ml)      .004 (.01)   .55     
Fasting glucose (mg/dl)       -.005 (.00)   .13   
Log HOMA-IR         -.013 (.07)   .86 
 
*Different from first trimester at p<.01. †Different from second trimester at p<.05. ‡Different from postpartum at p <.01. ¥Different from first trimester at p <.05. 
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Table 3.7:  Common carotid artery intima media thickness models adjusted for age, pre-pregnancy BMI, systolic blood pressure, weight change and individual 
biomarkers 
 
 
Adjusted for age, pre-
pregnancy BMI, SBP 
and weight change 
Adjusted for age, pre-
pregnancy BMI, SBP, 
weight change & total 
cholesterol 
Adjusted for age, pre-
pregnancy BMI, SBP, 
weight change & 
HDL-c 
Adjusted for age, pre-
pregnancy BMI, & 
Triglycerides 
Adjusted for age, pre-
pregnancy BMI, &   
LDL-c 
 Β (SE) P value Β (SE) P value Β (SE) P value Β (SE) P value Β (SE) P value 
Trimester 1 Ref  Ref  Ref  Ref  Ref  
Trimester 2 .018 (.01) .17 .016 (.02) .31 .016 (.01) .24 .013 (.01) .37 .017 (.01) .26 
Trimester 3 .041 (.02)*† .046 .040 (.02) .09 .038 (.02) .07 .035 (.02) .15 .041 (.02) † .06 
Postpartum .035 (.01)* .005 .030 (.01)* † .02 .028 (.01) .04* .031 (.01)* .02 .031 (.01)* .02 
Age (years) .003 (.00) .07 .003 (.00) .09 .003 (.00) .08 .003 (.00) .09 .003 (.00) .08 
Pre-pregnancy BMI (kg/m2) -.002 (.00) .35 -.002 (.00) .38 -.002 (.00) .34 -.003 (.00) .24 -.002 (.00) .39 
SBP (mmHg) .001 (.00) .04 .001 (.00) .05 .001 (.00) .04 .001 (.00) .01 .001 (.00) .05 
Weight change (kg) -.002 (.00) .07 -.002 (.00) .05 -.002 (.00) .04 -.003 (.00) .03 -.003 (.00) .04 
Total cholesterol (mg/dl)   -.000 (.00) .95       
HDL-c (mg/dl)     -.000 (.00) .39     
Triglycerides (mg/dl)       .000 (.00) .45   
LDL-c (mg/dl)         -.000 (.00) .80 
 
*Different from first trimester at p<.05. †Different from second trimester at p <.05. 
BMI is body mass index.  SBP is systolic blood pressure.  Weight change is from pre-pregnancy. 
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Table 3.7 Continued:  Common carotid artery intima media thickness models adjusted for age, pre-pregnancy BMI, systolic blood pressure, weight change 
and individual biomarkers   
 
 Adjusted for age, pre-
pregnancy BMI, SBP 
and weight change 
Adjusted for age, pre-
pregnancy BMI, SBP, 
weight change & 
hsCRP 
Adjusted for age, pre-
pregnancy BMI, SBP, 
weight change & 
fasting insulin 
Adjusted for age, pre-
pregnancy BMI, & 
fasting glucose 
Adjusted for age, pre-
pregnancy BMI, &   
log HOMA-IR 
 Β (SE) P value Β (SE) P value Β (SE) P value Β (SE) P value Β (SE) P value 
Trimester 1 Ref  Ref  Ref  Ref  Ref  
Trimester 2 .018 (.01) .17 .016 (.01) .24 .017 (.01) .22 .013 (.01 ) .33 .017 (.01) .21 
Trimester 3 .041 (.02)*† .046 .040 (.02) † .06 .042 (.02) *† .04 .039 (.02) † .06 .043 (.02)*† .04 
Postpartum .035 (.01)* .005 .032 (.01)* .01 .027 (.01)* .03 .032 (.01)* .01 .027 (.01)* .03 
Age (years) .003 (.00) .07 .003 (.00) .08 .003 (.00) .13 .003 (.00) .06 .002 (.00) .15 
Pre-pregnancy BMI (kg/m2) -.002 (.00) .35 -.002 (.00) .35 -.003 (.00) .42 -.002 (.00) .43 -.001 (.00) .71 
SBP (mmHg) .001 (.00) .04 .001 (.00) .04 .001 (.00) .01 .001 (.00) .04 .001 (.00) .02 
Weight change (kg) -.002 (.00) .07 -.003 (.00) .04 -.003 (.00) .06 -.002 (.00) .04 -.002 (.00) .07 
hsCRP (mg/L)   .000 (.00) .54     -.029 (.01) .02 
Fasting insulin (µU/ml)     -.002 (.00) .13     
Fasting glucose (mg/dl)       -.001 (.00) .09   
Log HOMA-IR         -.029 (.01) .02 
 
*Different from first trimester at p<.05. †Different from second trimester at p <.05. 
BMI is body mass index.  SBP is systolic blood pressure.  Weight change is from pre-pregnancy. 
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Table 3.8  Number of weeks postpartum as a continuous predictor 
 
 Unadjusted Adjusted for age and pre-pregnancy BMI Fully Adjusted* 
 ß (SE) p-value ß (SE) p-value ß (SE) p-value 
CCA IMT -.005 (.00)   .28 -.003 (.00) .42 -.007 (.00) .11 
IAD .009 (.04) .81 .018 (.02) .63 -.006 (.04) .87 
 
*Fully adjusted model for IMT:  age, pre-pregnancy BMI, SBP, weight change, log HOMA-IR.      
Fully adjusted model for IAD: age, pre-pregnancy BMI, SBP, triglycerides, log CRP. 
CCA IMT is common carotid artery intima media thickness.  IAD is inter-adventitial diameter.  BMI is 
body mass index (kg/m2). 
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All pairwise comparisons significant at p < .0001 EXCEPT:  Trimesters 1 vs. postpartum p = .76, Trimesters 2 vs. 3 p = .03.  Adjusted 
for age and pre-pregnancy body mass index. 
Figure 3.1 Changes in inter-adventitial diameter throughout pregnancy cycle  
Postpartum 
P < .0001 Inter-
Adventitial 
Diameter 
(mm) 
76 
Figure 3.2. Changes in CCA IMT throughout pregnancy cycle, adjusted for maternal age and pre-pregnancy BMI
Postpartum 
CCA 
IMT 
(mm) 
P = .042 
P = .009 
P = .018 
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4.1 ABSTRACT 
 
Objectives:  Higher parity is associated with greater subclinical cardiovascular disease (CVD) in 
mid-life and older women, and with higher risk of CVD overall.  Prospective studies of arterial 
change throughout normal pregnancy are lacking; without them it is unclear whether unhealthy 
changes of the vasculature during pregnancy persist postpartum and raise women’s risk of CVD.  
The goal of this study was to prospectively assess normal vascular adaptation in healthy pregnant 
women.  Our hypotheses were that during the course of healthy pregnancy brachial artery 
distensibility will not change. 
 
Methods:  The Maternal Vascular Adaptations to Healthy Pregnancy Study (Pittsburgh, PA, 
2010-2013) assessed 43 healthy women during each trimester of their first pregnancy and 6-8 
weeks postpartum. Brachial artery distensibility was measured using the DynaPulse wave form 
analyzer.  Linear mixed models were used to compare brachial artery distensibility at each time 
point, after adjustment for age and pre-pregnancy body mass index.  Various physical and 
cardiometabolic measures were then considered as mediators of the relationship between 
pregnancy and brachial artery distensibility. 
 
Results:  There were 37 women (age 28.2 ± 4.5 years, pre-pregnant BMI 24.4 ± 3.2 kg/m2) with 
uncomplicated pregnancies.  Mean (SE) brachial artery distensibility (%/mmHg) decreased from 
7.64 (0.28) 1st trimester to 6.84 (0.21) 3rd trimester (p < .01) and then remained unchanged at 
6.82 (0.21) postpartum. In multivariable models weight gain and increased cardiac output were 
significantly related to increased stiffness. 
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 Conclusions:  Contrary to our hypotheses, the brachial artery stiffened during pregnancy and 
remained stiffer 6-8 weeks postpartum.  Increased weight and cardiac output of pregnancy are 
associated with this change. Whether this indicates that persistence of specific vascular effects of 
pregnancy may inform long term CVD risk remains to be explored. 
 
 
4.2 INTRODUCTION 
 
Higher parity (number of births) is related to higher cardiovascular disease (CVD) risk in 
women,75-77  but the mechanisms for this higher risk are unknown.  It has long been thought that 
pregnancy’s acute effects on the vasculature are positive; both systemic vascular resistance and 
global (combined central and peripheral) arterial stiffness decrease during pregnancy.88,181   
Recent studies, however, suggest that the effects of pregnancy on the vasculature are more 
mixed.  They have found that the carotid artery actually stiffens during the course of 
pregnancy,171,194 is stiffer in pregnant women at greater gestational ages,206 and is stiffer in mid-
life and older women of higher parity.207  A recent study in elderly people showed that carotid 
stiffness is associated with greater risk of CVD;45 these findings may help explain the link 
between higher parity and greater CVD risk.  However, it is important to note that these studies 
were limited by lack of prospective data collection throughout pregnancy,206,207 small sample 
size,171,194 and lack of collection of data on hemodynamic and metabolic changes during 
pregnancy.171,194,206,207 
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Stiffness of the brachial artery has been shown to be related to CVD risk factors in young 
adults,208 but the effects of pregnancy on stiffness of the brachial artery have not been described.  
Distensibility of the brachial artery, a measure of peripheral arterial stiffness, can be measured 
easily,  reliably and non-invasively using the DynaPulse system (Pulse Metric, Inc., San Diego, 
CA).20  The DynaPulse has the advantage of simultaneously measuring several hemodynamic 
parameters known to change during pregnancy, including cardiac output, and thus can be used to 
gather prospective information on both changes in arterial stiffness during pregnancy and factors 
associated with those changes.  Understanding factors associated with changes in stiffness of the 
brachial artery during pregnancy may illuminate the relationship between pregnancy and CVD 
risk. 
An objective of the Maternal Vascular Adaption to Healthy Pregnancy (MVP) Study was 
to evaluate prospectively the normal changes in brachial artery distensibility that occur during 
uncomplicated first pregnancy.  A secondary objective was to explore the relationship between 
pre-conception and pregnancy-related factors and brachial artery distensibility.  We hypothesized 
that despite increases in fluid volume and weight, factors associated with higher arterial 
stiffness,209 the brachial artery would not stiffen during pregnancy. 
 
 
4.3 METHODS 
 
4.3.1 MVP Study Design and Population 
The MVP study prospectively assessed brachial artery distensibility in a cohort of healthy 
women experiencing their first pregnancies.  Participants were healthy non-smoking women, age 
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21-39 years, at less than 38 weeks gestational age in their first pregnancies.  Exclusion criteria 
were:  1) vasoactive medication use; 2) infertility history, defined as ever having had a period of 
at least 12 months of inability to achieve pregnancy, or using fertility medications to achieve 
pregnancy; 3) family history of premature coronary artery disease; and 4) multiple gestation.  
Participants were recruited with mailings and flyers distributed to the University of Pittsburgh 
community, use of University research registries, and advertisements in the offices of local 
(Pittsburgh, PA) prenatal care providers and on the internet.  All participants signed an informed 
consent document approved by the University of Pittsburgh Institutional Review Board. 
Study visits were scheduled at 12-14 weeks, 24-26 and 36-38 weeks of pregnancy, and at 
6-8 weeks postpartum, and occurred between June 2010 and March 2013.  After a telephone 
screening for eligibility, women could begin the study at any one of the pregnancy visits.  At 
each visit research staff obtained physical measures and staff of the University of Pittsburgh 
Ultrasound Research Laboratory obtained DynaPulse measurements of cardiovascular 
parameters.  Staff reviewed prenatal and birth records after the final study visit.  The targeted 
sample size of 46 women assumed that 10-20% of women would develop a pregnancy 
complication and that there would be 25% attrition from the study.  The study enrolled 44 
women, of whom 43 had multiple visits and 6 developed pregnancy complications, leaving 37 
women in the sample for this analysis.  This provided greater than 80% power to detect a 0.5 SD 
difference, given an assumed 0.5 correlation among the repeated observations. 
 
4.3.2 Brachial Artery Distensibility and Cardiac Output 
Brachial artery distensibility and cardiac output were measured using the DynaPulse 
5000A (Pulse Metric, Inc, San Diego, CA) by vascular sonographers from the University of 
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Pittsburgh Ultrasound Research Laboratory.  Participants rested in a seated position for 5 
minutes and then a standard cuff sphygmomanometer was attached to the left arm.  The cuff was 
automatically inflated for a calibration run; after calibration 3 runs were performed, and the 
mean of the 3 used for the analysis.  The offline waveform analysis of arterial pressure signals 
performed by PulseMetric, Inc. uses validated models of the vascular system to calculate 
cardiovascular parameters.20   The brachial artery distensibility coefficient is calculated as 
change in volume divided by change in pressure, or as 4π/(dP/dtpp*tpp), where dP/dtpp is the 
amplitude from the peak positive pressure derivative to the peak negative pressure derivative of 
oscillometric pulsation signal and tpp is the interval between the peak positive and peak negative 
pressure derivatives.208  To calculate cardiac output, dP/dtpp was used to approximate left 
ventricular dP/dtpp, and a Gaussian transformation function was then used to calculate left 
ventricular contractility (LVC).  Cardiac output was calculated as cardiac output = LVC * heart 
rate * body surface area.  Body surface area was calculated  as a function of weight and height.210 
Validation studies of the methods have been published, with a linear regression correlation of r = 
0.83 for compliance compared with measurements from intraarterial cannulation.20 
 
4.3.3 Demographic, Physical and Laboratory Measures 
Women completed a self-administered demographic form with information on age, 
race/ethnicity, marital status, education, employment, income, insurance status and intended 
birth site at their initial study visit.  Each visit included physical measures, vascular evaluation, 
and laboratory assays.  Research staff measured height with the participant not wearing shoes 
using a stadiometer, and the mean of 2 readings from the first visit used.   Lightly clothed 
participants were weighed on a standard balance scale and the mean of 2 readings used.  Pre-
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pregnancy weight was identified as the pre-pregnancy weight documented in the prenatal record 
or, if not available, as a documented weight in the health record in the three months prior to the 
last menstrual period.  Pre-pregnancy body mass index (BMI) was calculated as pre-pregnancy 
weight in kilograms divided by height in meters squared.  Weight change was calculated as the 
difference between weight at each study visit and pre-pregnancy weight. 
Blood pressure was measured according to standardized protocol.  After participants 
rested for 5 minutes in a quiet room, research staff palpated the right radial pulse for 30 seconds 
and then measured blood pressure in that arm using a mercury sphygmomanometer, with 
auscultation of the 5th Korotkoff sound indicating diastolic pressure.  The mean of the last 2 of 3 
measurements was used for the analysis.  Data on demographic and physical measures and from 
records reviews were collected and managed using REDCap electronic data capture tools hosted 
at the University of Pittsburgh.195   REDCap (Research Electronic Data Capture) is a secure, 
web-based application designed to support data capture for research studies, providing 1) an 
intuitive interface for validated data entry; 2) audit trails for tracking data manipulation and 
export procedures; 3) automated export procedures for seamless data downloads to common 
statistical packages; and 4) procedures for importing data from external sources. 
Laboratory assays were performed on fasting serum samples at the Heinz Nutrition 
Laboratory at the University of Pittsburgh Graduate School of Public Health (Pittsburgh, PA).  
Total cholesterol,196 high density lipoprotein (HDL-c),197 low density lipoprotein (LDL-c)198, 
triglycerides199 and glucose200 were determined using standard laboratory procedures. Insulin 
was measured using standard radio-immune assay (Linco Research, St. Charles, MO). HOMA-
IR, a measure of insulin resistance, was calculated as (glucose x insulin)/405. 201  High-
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sensitivity C-reactive protein (hsCRP) was measured with an enzyme-linked immunoassay 
(Alpha Diagnostics International, Inc. San Antonio, TX).   
 
4.3.4 Statistical Analysis 
Distributions were assessed for all variables.  Measures with approximately normal 
distributions are presented as means ± standard deviations (SD); measures not normally-
distributed are presented as medians with interquartile range, and categorical variables are 
presented as percentages.  hsCRP and HOMA-IR were skewed and were log-transformed to meet 
the linear assumptions of regression modeling.  Longitudinal measures that were collected over 
time (brachial artery distensibility, physical, and laboratory measures) are presented for each of 
the 4 time points in the study.  Linear mixed models were used to calculate 1) estimated mean 
brachial artery distensibility adjusted for maternal age and pre-pregnancy BMI, and indicators of 
each trimester and postpartum; 2) the overall effect of time in the pregnancy cycle on 
distensibility; and 3) which specific time points (trimester, postpartum) vary from each other.   
To determine associations between cardiovascular risk factors and distensibility a 
hierarchical regression analysis was used. Models were constructed including time-varying 
systolic blood pressure, weight, weight change, heart rate and cardiac output. Maternal age and 
pre-pregnancy BMI were a priori included in all models.  Significant predictors (systolic blood 
pressure, weight, weight change and cardiac output) were included in the full models and, and 
statistically significant predictors were retained in a best model.  Next, biomarkers were tested 
individually in the best model.  Biomarkers with statistical significance (glucose, HDL, 
triglycerides and hsCRP) were then modeled together, and only statistically significant factors 
were retained.  A sensitivity analysis was performed eliminating 3 outliers for hsCRP, and 
85 
another was done including only the 15 women who completed all study visits.  To assess 
whether distensibility changes over the course of the postpartum period, simple linear regression 
was performed using weeks postpartum as a continuous predictor of brachial artery distensibility. 
A two-sided p-value of <.05 was considered statistically significant.  All analyses were 
performed using SAS statistical software Windows 9.3 (SAS Institute, Cary, NC). 
 
4.4 RESULTS 
 
Participants’ average age at baseline was 28.4 ± 4.6 years and average BMI was 24.3 ± 
3.3 (kg/m2).  A majority were white (91.9%), married or living as married (89.2%), well-
educated (89.2% college graduate or greater) and employed (64.9% full time, 24.3% part time).   
The mean number of visits was 3.3 (range 2-4), with 15 women completing all 4 visits.   
The brachial artery stiffened between the first and second trimesters, and remained stiffer 
into the postpartum period.  Distensibility decreased from 7.50 %/mm Hg in the 1st trimester to 
7.01 %/mm HG 2nd in the second trimester, and then remained stable into the postpartum period 
(overall P = .049) (Table 4.1).  After adjustment for maternal age and pre-pregnancy BMI, this 
pattern remained the same (P=.035) (Figure 4.1).   
Changes in weight, blood pressure, heart rate, cardiac output, and lipid, glucose and 
hsCRP concentrations followed expected patterns for healthy pregnancies (Table 4.1).  When 
weight and hemodynamic factors were assessed, lower brachial artery distensibility was 
associated with higher systolic blood pressure, higher weight, greater weight change, and greater 
cardiac output (Table 4.3).  When modeled together, greater weight gain and cardiac output 
remained significantly associated with a stiffer brachial artery (Table 4.2).  These substantially 
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changed the pattern of change in arterial stiffness seen throughout pregnancy (Table 4.2), with 
only the postpartum value becoming significantly different from the 1st trimester value.  
When metabolic factors were considered individually (Table 4.4) higher HDL-c 
concentrations were associated with a stiffer brachial artery and higher triglycerides, glucose, 
and hsCRP concentrations were associated with lower stiffness. After modeling the significant 
metabolic factors together, only hsCRP remained significantly associated with lower stiffness 
(Table 4.2).  Including hsCRP substantially changed the beta coefficient for the postpartum 
period, from -0.735 (0.01) to -0.368 (.29).  Results of all analyses were consistent of those from 
the sensitivity analysis including only the women who completed all 15 study visits (data not 
shown).  
Final visits were conducted at 6-13 weeks postpartum, with a mean of 8.6 weeks.  At the 
postpartum visit, 88% of women were fully breastfeeding their infants. Number of weeks 
postpartum was not significantly related to distensibility (data not shown). 
 
4.5 DISCUSSION 
 
This study evaluated changes in brachial artery distensibility during the course of normal 
first pregnancy, and found that the brachial artery stiffened between the first and second 
trimesters, and then remained stiffer than first trimester values at 6 to 8 weeks postpartum.  This 
was contrary to our hypothesis that the artery would not stiffen during pregnancy.  These 
changes were associated with greater weight gain and increase in cardiac output during 
pregnancy, suggesting these factors mediate the change.  Brachial artery distensibility was not 
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associated with blood pressure independent of changes in weight, and was associated with 
several markers of inflammation, including hsCRP, triglyceride, and glucose concentrations. 
These findings support the observation that the pregnancy’s effect on the vasculature 
differs by vascular bed.  While overall systemic resistance decreases and the aorta becomes more 
compliant during pregnancy, mounting evidence shows that the carotid artery stiffens.171,194,206,207  
Our study found that the brachial artery also stiffened during healthy pregnancy.  The 
mechanism for the different effects on different arterial beds is unknown.  It has been speculated 
that the carotid artery and aorta may express different proportions of receptors for estrogen and 
angiotensin II,171 and that this may explain the varied effects of pregnancy. 
These findings are consistent with research showing that change in arterial stiffness is 
strongly related to weight change in young adults.  In an observational study, weight change over 
a 2 year period was significantly related to change in aortic stiffness in 20-40 year old adults, 
independent of aging and changes in blood pressure.209  A clinical trial examining a weight loss 
intervention coupled with a low sodium diet found that weight loss over a 6 month period was 
associated with decreased arterial stiffness, again independent of changes in blood pressure.188 
The mechanism of these changes is unknown, but researchers have speculates that weight gain is 
independently related to increased vascular stiffness.211  Our study measured cardiac output, and 
strongly suggests that in pregnancy weight gain and increased cardiac output were related to the 
increased arterial stiffness.  Consistent with findings from the Cardiovascular Risk in Young 
Finns study,206 lipid concentrations were not independently related to arterial stiffness. 
There are several theories explaining the relationship between high parity and higher risk 
of CVD, including persistence of acute changes of pregnancy,85,174 long-term effects of 
accumulated CVD risk factors following pregnancies,67,69,70 and confounding based on 
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socioeconomic and lifestyle factors.81,212  Our findings suggest that persistence of an acute 
pregnancy change, stiffening of the brachial artery, may be one piece of the equation.  The 
studies cited above209 suggest that weight loss after pregnancy should result in improved arterial 
stiffness, but it is unknown if there will be a complete reversal.  Some mechanisms of stiffening, 
such as changes in endothelial function, are reversible; others, however, including fragmentation 
of elastin or changes in collagen and protein cross-linking may not be.21,209  Persistent greater 
arterial stiffness may contribute to higher CVD risk largely through its effects on increasing 
systolic blood pressure.21  Long term follow up studies are needed to determine whether the 
arterial stiffening seen during pregnancy persists. 
The finding that brachial artery stiffness was negatively related to several measures of 
inflammation, while HDL-c was related to higher stiffness, was unexpected.  Perhaps the 
hormonal milieu of pregnancy, which includes very high levels of sex hormones and relaxin, 
may have a protective effect on the vasculature from what may normally be negative metabolic 
changes. 
These findings also may have implications for research into pregnancy complications, 
particularly preeclampsia.  Preeclampsia is a pregnancy-specific disease characterized by new 
onset hypertension after 20 weeks of pregnancy and proteinuria.  Peripheral arterial stiffness in 
pregnancy has been found to be higher in pregnancies complicated by preeclampsia than in 
healthy pregnancies in some,179,180 but not all studies,161  and at 16 months postpartum.183  Our 
findings provide baseline data that can be used in future research examining patterns of arterial 
stiffness in healthy pregnancies compared to pregnancies complicated by preeclampsia.  The 
DynaPulse device is easily used in the outpatient setting, and could be a useful clinical tool. 
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This study was to our knowledge the first to prospectively follow a cohort of pregnant 
women into the postpartum period with a reliable measure of brachial artery distensibility and 
concurrent collection of various hemodynamic and metabolic measures.  It benefited from high 
retention of participants.  However, there were some notable limitations to the study.  It was 
limited by the timing of the visits. The first visit did not occur until 12-14 weeks of pregnancy.  
Substantial hemodynamic changes occur as early as 5 weeks of pregnancy,88 so it is likely that 
our first visit does not represent a true pre-pregnancy baseline.  Pre-pregnancy weights were 
largely self-reported; it has been shown that women tend to under-report pre-pregnant weight.213  
The postpartum visit was performed at an average of 8 weeks postpartum.  It is likely that not all 
of the hemodynamic changes of pregnancy have resolved at that point90 and longer follow-up is 
required to determine if the increased brachial artery stiffness persists.  Participants were 
overwhelmingly breastfeeding at that point, and the results might not reflect those in women 
formula feeding their infants.  The power calculations for the study were based on the 
assumption that women would attend all 4 study visits; in actuality, women attended an average 
of 3.3 visits, decreasing the power of the study.  However, the change in brachial artery 
distensibility was greater than that posited, providing sufficient power to detect significant 
differences.  The sensitivity analysis including only the 15 women completing all visits 
replicated all findings, confirming that failure to attend all the study visits did not negatively 
affect the results. 
The largely white, well-educated women in this cohort may not be representative of the 
general population of first time pregnant women, yet the study has utility as providing baseline 
data against which arterial stiffness changes in other demographic groups can be assessed. 
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The results of this study apply only to the brachial artery, and cannot be assumed to apply 
to the rest of the arterial bed, which has indeed been demonstrated to have increased compliance 
during pregnancy.  Brachial artery distensibility is a less studied measure than the more 
frequently used pulse wave velocity, and its relationship to future CVD is not well understood, 
although it is associated with coronary artery calcification, and independent predictor of CVD 
risk.214  Brachial artery distensibility has rarely been studied in pregnancy, and validity and 
reliability of the measure in pregnancy are not well understood.  Yet, if these are demonstrated, 
the measure may have great utility because of its ease of use. 
We found that the brachial artery stiffens between the first and second trimesters of a 
healthy first pregnancy, and remains stiffer at 6-8 weeks postpartum.  This change appears to be 
explained by the increased weight and cardiac output that occur during pregnancy, and is 
independent of changes in blood pressure. Several inflammatory markers are associated with 
greater stiffening, but after multivariable adjustment only hsCRP was independently associated.  
This stiffening is similar to stiffening demonstrated in the carotid artery, but different from the 
increased compliance seen in the aorta.  Understanding normal arterial changes may allow for 
better understanding of the physiology of pregnancy complications and identify women at risk 
for complications early in pregnancy.  The relationship between parity and future CVD is 
complex and likely multifactorial, however if this stiffening of the brachial artery persists, it may 
help explain the greater CVD risk in women of higher parity. 
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4.6 TABLES AND FIGURES 
Table 4.1 Unadjusted values for outcomes and key time-varying covariates by trimester 
1st Trimester 
n=17 
2nd Trimester 
n=32 
3rd Trimester 
n=37 
Postpartum 
n=35 P value 
BrachD (%/mm Hg) 7.50 (.20) 7.01 (.21) 6.93 (.22) 6.95 (.17)  .049 
Weight (kg) 68.7 (2.2) 73.1 (1.6) 79.5 (1.8) 69.2 (1.5) <.0001 
Weight change(kg) .55 (.46) 7.27 (.62) 14.4 (.91) 4.3 (.75) <.0001 
Systolic blood pressure (mm Hg) 103.7 (2.1) 106.0 (1.7) 110.4 (1.4) 106.2 (1.7)  .0005 
Diastolic blood pressure (mm Hg) 61.8 (1.6) 61.3 (1.2) 68.4 (1.2) 68.7 (1.2) <.0001 
Pulse pressure (mm Hg) 42.2 (1.9) 44.3 (1.5) 41.9 (1.5) 37.6 (1.5) <.0001 
Cardiac Output (L/min) 5.24 (.25) 5.71 (.23) 6.23 (.23) 4.46 (.10) <.0001 
Heart Rate (bpm) 78.0 (2.4) 79.8 (1.6) 82.0 (1.5) 68.1 (1.5) <.0001 
Total Cholesterol (mg/dl) 201.7 (8.9) 257.3 (7.0) 273.1 (7.2) 191.4 (5.5) <.0001 
LDL-c (mg/dl) 111.2 (7.0) 148.0 (6.3) 155.5 (6.6) 114.7 (4.8) <.0001 
Triglycerides (mg/dl) 108.3 (10.5) 176.5 (10.2) 250.7 (13.6) 77.3 (7.0) <.0001 
HDL-c (mg/dl) 68.8 (2.2) 74.0 (3.1) 66.8 (2.3) 61.2 (1.8) <.0001 
Glucose (mg/dl) 79.3 (1.5) 77.2 (1.1) 77.0 (1.2) 82.6 (1.2)  .0007 
Insulin (µU/ml) 8.84 (.78) 11.25 (.98) 11.95 (.81) 8.59 (.50)  .0001 
HOMA-IR* 1.64 [1.32, 2.09] 2.16 [1.56, 2.56] 2.28 [1.67, 2.51] 1.77 [1.34, 2.13]   .01 
HS-CRP* (mg/L) 3.58 [2.16, 5.57] 3.36 [2.31, 5.49] 3.29 [2.24, 7.01] 1.20 [.77, 2.44] <.0001 
Values presented as mean (SE) or median [IQR]. 
*p-values from Wilcoxon rank-sum test
BrachD is brachial artery distensibility.  Weight change is from pre-pregnancy. 
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Table 4.2 Association between covariates and brachial artery distensibility coefficient 
Main Effect and Covariates Unadjusted Minimally Adjusted Final Model 
β (SE) P value β (SE) P value β (SE) P value 
Trimester 1 Ref Ref Ref 
Trimester 2 -0.581 (.27)* 0.03 -0.595 (.27)* 0.03 0.214 (.30) ‡  0.48 
Trimester 3 -0.711 (.26)* 0.01 -0.732 (.26)* 0.01 0.846 (.42) †‡  0.05 
Postpartum -0.720 (.28)* 0.01 -0.744 (.27)* 0.01 -0.735 (.26)*  0.01 
Baseline Age (yr) 0.000 (.03) 0.997 -0.076 (.03)  0.02 
Pre-pregnancy BMI (kg/m2) -0.086 (.05) 0.08 0.002 (.05)  0.96 
Weight change (kg) -0.074 (.03)  0.01 
Cardiac Output (L/min) -0.486 (.10) <0.0001 
*Different from first trimester at p<.05. †Different from second trimester at p<.05. ‡Different from postpartum at p <.01.
** Without CRP outliers. 
Model 1:  Adjusted for age & pre-pregnancy BMI 
Model 2: Adjusted for age, pre-pregnancy BMI, weight change & cardiac output 
Model 3: Adjusted for age, pre-pregnancy BMI, weight change, cardiac output & Log HS-CRP** 
BMI is body mass index.  Weight change is from pre-pregnancy. 
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Table 4.3: Brachial artery distensibility coefficient models adjusted for age and pre-pregnancy BMI with individual predictors
Adjusted for age & 
pre-pregnancy BMI 
Adjusted for age, 
pre-pregnancy BMI, 
& SBP 
Adjusted for age, 
pre-pregnancy BMI, 
& wt 
Adjusted for age, pre-
pregnancy BMI & wt 
change 
Adjusted for age, pre-
pregnancy BMI & 
cardiac output 
Adjusted for age, 
pre-pregnancy BMI 
& heart rate 
β (SE) P value β (SE) P value β (SE) P value β (SE) P value β (SE) P value β (SE) P value 
Trimester 1 Ref Ref Ref Ref Ref¥ Ref 
Trimester 2 -.595 (.27) .03 -.587 (.26)* .03 -.315 (.29) .28 -.047 (.32) .88 -.211 (.25) ¥ .40 -.638 (.27)* .02 
Trimester 3 -.732 (.26)* .01 -.533 (.28) .06 -.032 (.38)‡ .93  .491 (.47) ¥ .30 -.080 (.25) ¥ .75 -.727 (.27)* .01 
Postpartum -.744 (.27)* .01 -.707 (.28)* .01 -.626 (.28)* .03 -.462 (.29) .12 -1.00 (.24) <.0001 -.809 (.30)* .01 
Age (yr)  .000 (.03) .997 -.011 (.03) .75 -.031 (.04) .38 -.029 (.03) .38 -.057 (.03) .08  .001 (.03) .99 
Pre-pregnancy BMI (kg/m2) -.086 (.05) .08 -.040 (.05) .44  .046 (.07) .51 -.087 (.05) .06  .015 (.05) .75  .128 (.05) .13 
SBP (mm Hg) -.030 (.01) .02 
Weight (kg) -.054 (.02) .01 
Weight change (kg) -.091 (.03) .00 
Cardiac output (L/min) -.539 (.10) <.0001 
Heart rate (bpm) -.002 (.01) .87 
*Different from first trimester at p<.05. †Different from second trimester at p<.05. ‡Different from postpartum at p <.05. ¥Different from postpartum at p <.01.
BMI is body mass index.  SBP is systolic blood pressure.  Weight change is from pre-pregnant. 
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Table 4.4: Brachial artery distensibility coefficient models adjusted for age, pre-pregnancy BMI, weight change and cardiac output with individual biomarkers 
Adjusted for age & 
pre-pregnancy BMI 
Adjusted for age, pre-
pregnancy BMI, 
weight change and 
cardiac output 
Adjusted for age, pre-
pregnancy BMI, weight 
change, cardiac output 
& total cholesterol 
Adjusted for age, pre-
pregnancy BMI, weight 
change, cardiac output 
& total HDL 
Adjusted for age, 
pre-pregnancy BMI, 
weight change, 
cardiac output & 
triglycerides 
Adjusted for age, pre-
pregnancy BMI, 
weight change, cardiac 
output & LDL 
β (SE) P value β (SE) P value β (SE) P value β (SE) P value β (SE) P value β (SE) P value 
Trimester 1 Ref Ref Ref Ref Ref Ref 
Trimester 2 -.595 (.27)* .03  .214 (.30) ‡   .48 .360 (.35)  .31 .423 (.31)  .17 .142 (.33) .66 .378 (.33)  .26 
Trimester 3 -.732 (.26)* .01 .846 (.42) †‡   .05 .985 (.47)* †¥  04 .922 (.42)*¥  .03 .621 (.51) ‡ .22 1.00 (.45)* †¥   .03 
Postpartum -.744 (.27)* .01 -.735 (.26)*  .01 -.579 (.28)* †  .04 -.073 (.27)*¥  .01 -.042 (.28) .15 -.575 (.28)*†   .04 
Age (yr)  .000 (.03) .997 -.076 (.03)  .02 -.077 (.03)  .01 -.074 (.03)  .03 -.074 (.03) .66 -.077 (.03)  .02 
Pre-preg BMI (kg/m2) -.086 (.05) .08   .002 (.05)  .96 -.006 (.05)  .89 -.012 (.05)  .81 -.015 (.05) .76 -.006 (.05)  .90 
Weight change (kg) -.074 (.03)  .01 -.076 (.03)  .00 -.076 (.03)  .00 -.087 (.03) .00 -.076 (.03)  .00 
Cardiac output (L/min) -.486 (.10) <.0001 -.472 (.10) <.0001 -.473 (.10) <.0001 -.386 (.10) .0004 -.471 (.10) <.0001 
Total cholesterol (mg/dl) -.000 (.00)  .97 
HDL-c (mg/dl) -.017 (.01)  .02 
Triglycerides (mg/dl)  .003 (.00) .045 
LDL-c (mg/dl) -.001 (.00)  .83 
*Different from first trimester at p<.05. †Different from second trimester at p<.05. ‡Different from postpartum at p <.05. ¥Different from postpartum at p <.01.
Pre-preg BMI is pre-pregnancy body mass index, weight change is from pre-pregnancy, HDL-c is high density lipoprotein concentration, LDL-c is low density lipoprotein concentration. 
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Table 4.4 Continued: Brachial artery distensibility coefficient models adjusted for age, pre-pregnancy BMI, weight change and cardiac output with individual biomarkers 
Adjusted for age & 
pre-pregnancy BMI 
Adjusted for age, pre-
pregnancy BMI, weight 
change and cardiac 
output 
Adjusted for age, pre-
pregnancy BMI, weight 
change, cardiac output 
& insulin 
Adjusted for age, pre-
pregnancy BMI, weight 
change, cardiac output 
& glucose 
Adjusted for age, pre-
pregnancy BMI, weight 
change, cardiac output 
& log HOMA 
Adjusted for age, pre-
pregnancy BMI, weight 
change, cardiac output & 
log HS-CRP 
β (SE) P value β (SE) P value β (SE) P value β (SE) P value β (SE) P value β (SE) P value 
Trimester 1 Ref Ref Ref Ref Ref Ref 
Trimester 2 -.595 (.27)* .03  .214 (.30) ‡   .48   .365 (.31) .25   .509 (.32) †   .11   .374 (.31) .24   .358 (.29)   .23 
Trimester 3 -.732 (.26)* .01 .846 (.42) †‡   .05 1.09 (.44)* †¥ .02 1.29 (.44)* †¥   .00 1.12 (.44)* †¥ .01  .951 (.42) * †¥   .03 
Postpartum -.744 (.27)* .01 -.735 (.26)*   .01 -.541 (.28) † .06 -.585 (.29)*   .049 -.532 (.28) † .06 -.320 (.26) †   .23 
Age (yr)   .000 (.03) .997 -.076 (.03)   .02 -.078 (.03) .02 -.086 (.03)   .01 -.076 (.03) .02 -.082 (.03)   .02 
Pre-preg BMI (kg/m2) -.086 (.05) .08  .002 (.05)   .96 -.007 (.05) .88 -.020 (.05)   .67 -.014 (.05) .78 -.019 (.05)   .70 
Weight change (kg) -.074 (.03)   .01 -.084 (.03) .00 -.092 (.03)   .00 -.089 (.03) .00 -.075 (.03)   .01 
Cardiac output (L/min) -.486 (.10) <.0001 -.404 (.11) .0004 -.444 (.11) <.0001 -.421 (.11) .0002 -.490 (.10) <.0001 
Insulin (µU/ml) -.013 (.02) .58 
Glucose (mg/dl)   .028 (.01)   .049 
Log HOMA   .041 (.29) .89 
Log hsCRP   .289 (.10)   .003 
*Different from first trimester at p<.05. †Different from second trimester at p<.05. ‡Different from postpartum at p <.05. ¥Different from postpartum at p <.01.
Pre-preg BMI is pre-pregnancy body mass index, weight change is from pre-pregnancy, HOMA is homeostasis model assessment, hsCRP is high-sensitivity C-reactive protein. 
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Brachial Artery 
Distensibility 
(%/mm Hg) 
Postpartum 
P = .035 
P = .028 
P = .006 
P = .007 
Figure 4.1:  Estimated brachial artery distensibility adjusted for age and pre-pregnancy body mass index 
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5.0 CONCLUSIONS AND PUBLIC HEALTH SIGNFICANCE 
5.1 CONCLUSION 
The preponderance of epidemiologic studies demonstrate a J-shaped relationship between 
parity and CVD risk in women, with lowest risk in women with 2 or 3 births, but the reasons for 
this relationship are not well-understood.76-78  Elevated risk in women with one or no births 
might be due to generally poorer health in women who have difficulty bearing children, or due to 
the fact that pregnancies produce beneficial effects on the cardiovascular system.  The elevated 
risk that occurs with more births could be an example of antagonistic pleiotropy, in which 1 or 2 
completed pregnancies have a positive effect on the cardiovascular system but more have a 
negative effect, or be due to the long term effects from accumulation of CVD risk factors with 
multiple pregnancies.  Additionally, lower SES is associated with higher parity, more CVD risk 
factors (less healthy lifestyle), and greater CVD risk, and may confound the relationship.80,212 
This dissertation sheds light on both ends of this relationship.  Paper 1 demonstrates that 
2 markers of arterial health were worse in nulliparous young, overweight or obese women, than 
in the parous comparison group.  Nulliparous women (n=70, age 34.9 ± 7.1) had higher common 
carotid IAD (.230 mm, SE .08, P = .006) and mean CCA IMT (.031 mm, SE .01, P = .009) 
compared with parous women (n=102, age 39.5 ± 4.9) after adjustment for age, race, and CVD 
risk factors.  This difference was similar in magnitude to the difference seen in women with 
histories of documented infertility in the sample.  This suggests that in this sample higher IAD 
and CCA IMT may be related to undiagnosed fertility problems. 
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Papers 2 and 3 describe prospective structural and functional changes that occur in large 
more elastic arteries (carotid artery) and medium-sized more muscular peripheral arteries 
(brachial artery) throughout the course of the normal first pregnancy and early postpartum, and 
shed light on the higher CVD risk in women of high parity.  These papers found 2 negative 
vascular changes that occur during pregnancy and persist until at least 8 weeks postpartum: 
increased CCA IMT and decreased brachial artery distensibility.  The increased CCA IMT is not 
well explained by the atherogenic cardiometabolic changes of pregnancy, and may simply be a 
response to the increased IAD and hemodynamic changes of pregnancy.  The increased stiffness 
of the brachial artery appears to be explained by the increased weight and cardiac output of 
pregnancy, consistent with studies of non-pregnant young adults.209  It has long been thought that 
pregnancy’s acute effects on the vasculature are positive; both systemic vascular resistance and 
global (combined central and peripheral) arterial stiffness decrease during pregnancy.88,181   
Recent studies, however, suggest that the effects of pregnancy on the vasculature are more 
mixed.  They have found that the carotid artery actually stiffens during the course of 
pregnancy,171,194 is stiffer in pregnant women at greater gestational ages,206 and is stiffer in mid-
life and older women of higher parity.207 Our work supports this new understanding that 
pregnancy’s effects on the vasculature differ by vascular bed.  If the increased CCA IMT and 
brachial artery distensibility persist long term, they may help explain the relationship between 
high parity and greater CVD risk. 
Our research succeeded in illuminating several parts of the conceptual model presented in 
Figure 2.5.   Paper 1, which finds markers of less healthy arteries in nulliparous women 
comparable to those found in infertile women, suggests that there is a relationship between the 
health of the systemic vasculature and the ability of women to conceive and carry healthy 
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pregnancies.  Papers 2 and 3 describe prospectively the remodeling of the systemic vasculature 
during pregnancy, and also demonstrate how those changes persist into the early postpartum 
period. They explore the effects of physiological changes of pregnancy on these measures. They 
suggest that the weight gain and increased cardiac output of pregnancy largely explains the 
increased brachial artery stiffness that we observed, and that the changes in the carotid artery are 
largely independent of factors traditionally related to atherosclerosis.  Reproductive history may 
provide important information about cardiovascular disease risk independent of traditional CVD 
risk factors. 
There are several areas of future work for this dissertation.  The analysis in Paper 1 
should be replicated in other samples of women.  The largely white, educated sample of 
overweight and obese young women is not representative of the general US population.  It 
should be replicated in women of healthy weight and more diverse racial and SES backgrounds.  
If these findings of worsened vascular health in nulliparous women are validated, it could 
provide an important additional risk factor for identifying women at elevated risk of CVD.   
The first step in future research stemming from the MVP study is to assess the women 
again at 2-3 years after their last study visit, to determine if the negative vascular changes 
identified as occurring during their first pregnancies persist past the early postpartum period.  
This study is currently in process, and will provide important information on whether these 
changes persist.  MVP needs to be replicated in a larger sample, and more diverse populations.  
Ideally, pre-pregnancy measures of vascular, physical and metabolic measures can be obtained 
so that it can be determined if these affect the changes that occur, as well as what changes occur 
early in the first trimester of pregnancy.  Additionally, this study, which focuses on the normal 
vascular changes that occur during healthy first pregnancy, has potential to illuminate the many 
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pregnancy complications that are associated with abnormal vascular remodeling.  Cross-sectional 
studies demonstrate greater IMT and vascular stiffness in women with pregnancy complications 
such as preeclampsia (See Tables 6.1 and 6.3 in Appendix 1).  Prospective studies are needed 
that include more women who develop pregnancy complications.  These could tell us whether 
women who develop pregnancy complications have less healthy arteries pre-pregnancy or 
whether they start pregnancy with arteries similar to those of women with healthy pregnancy but 
vascular remodeling goes awry during the course of pregnancy.  If the first is true, research is 
needed on whether pre-conception risk reduction may decrease incidence of pregnancy 
complications.  If the latter is true, it might provide considerable insight into the pathophysiology 
of pregnancy complications, and provide early markers for women at risk. 
 
5.2 PUBLIC HEALTH SIGNIFICANCE 
 
Cardiovascular disease is the leading cause of death in women, causing more than 
340,000 deaths in 2010.215  Even small decreases in risk can lead to substantial number of lives 
saved.  Identification of nulliparity as a risk factor for CVD may contribute to the ability of 
clinicians to efficiently screen for women at elevated CVD risk in order to provide targeted risk 
reduction efforts to a population at risk.  Nulliparity is a risk factor that can be detected in the 
first half of a woman’s life, allowing for an extended period of time for risk reduction to have an 
effect.  While epidemiologic studies have found only about a 10% higher risk of CVD in 
nulliparous women, as opposed to a 50% higher risk in women of parity of 5 or greater,77 the 
proportion of nulliparous women in the population is much higher than the proportion of women 
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of high parity in the United States,216 leading to a greater population attributable risk in this 
group. 
This research may also contribute to an understanding of how pregnant women can 
decrease the negative relationship between parity and CVD. In paper 3 we demonstrate that 
greater pregnancy weight gain is related to greater stiffening of the brachial artery, a CVD risk 
factor.  Currently, the Institute of Medicine recommends upper limits for healthy pregnancy 
weight gain, but these are based on maximizing fetal, not maternal, well-being.185  The 
committee writing the current recommendations was ”unable to identify any published studies 
that examined a direct association between GWG (gestational weight gain) and the development 
of cardiovascular disorders later in life.”185  If findings that greater gestational weight gain is 
related to greater arterial stiffness and that this stiffness persists long term, this would provide 
support for the idea that limiting pregnancy weight gain to recommended levels is healthy not 
just for the fetus but also for the woman herself. 
Paper 2’s description of the normal vascular changes in healthy pregnancy may serve to 
illuminate some of the most perplexing issues in pregnancy care.  Precise causes of 
preeclampsia, intrauterine growth restriction and preterm birth are not well understood, but there 
is evidence that many cases of these conditions have vascular components1-5,52  and that 
preeclampsia specifically is associated with abnormal adaptation of the carotid artery.156-158,161,162  
Preeclampsia affects 2-8% of US pregnancies55 and preterm birth 12%.60  A better understanding 
of the mechanisms of vascular adaptation to healthy pregnancy may provide a basis for better 
understanding of the pathophysiology of these pregnancy complications, and perhaps lead to 
means for early identification of women at risk, or even to prevention. 
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APPENDIX:  Review of Literature 
Table A.1 Studies of Intima-Media Thickness and Preeclampsia 
Author Study 
Design 
Population 
& Sample 
Size 
Definition of 
Preeclampsia 
Outcome 
Assessed 
When 
Assessed 
Confounders Results 
Andersgaard 
et al. (2012) 
Population-
based 
Cross-
sectional 
data 
Norway 
Participants: 
2524 total 
History of 
preeclampsia: 
250 
No HTN or 
proteinuria:  
1778 
Average age 
48 yo 
Average BMI 
25-26 
Self-report.  “If you have 
had high blood pressure 
during pregnancy, was it 
your first pregnancy?” and 
“If you have had 
proteinuria during 
pregnancy, was it your 
first pregnancy?”  If they 
replied they had both 
hypertension and 
proteinuria, counted as 
preeclampsia. 
IMT – mean 
of near & far 
walls of 
CCA & far 
wall of bulb. 
Average 25 
years 
postpartum 
IMT is age-
adjusted 
Women reporting 
PE had higher 
MAP, SBP, DBP, 
total cholesterol, 
triglycerides, 
BMI, waist 
circumference.   
Mean IMT 0.86 mm (95% CI 0.84-0.89) 
for women with PE vs. 0.82 (95% CI 
0.81-0.83) for women without HTN or 
proteinuria (.01>p>.001). 
Berends et 
al. (2008) 
Case-control 
Cross-
sectional 
data 
Netherlands 
Participants: 
History of 
PE: 56 
Normal 
pregnancy: 
106 
Average age: 
36 for cases, 
39 for 
controls. 
Cases identified from 
National Birth 
Registration Records.  All 
records reviewed by 
author.  PE: de novo 
hypertension (SBP>=140, 
DBP >=90) & proteinuria 
>=300mg/24 hours or 
>=1+ on semiquantitative 
analysis  
CCA IMT 
bilaterally. 
Time from 
birth: 7 years 
for cases, 13 
years for 
controls. 
Women with PE 
had higher BMI, 
larger waist 
circumference, 
higher SBP 
&DBP, higher 
blood glucose, 
more frequent 
metabolic 
syndrome. 
Median IMT 0.66 mm for women with 
PE vs. 0.68 mm for controls.  For 
women with PE, those with HTN had 
greater IMT than those without; no 
difference among controls when 
stratified by HTN. 
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Table A.1 Continued  Studies of Intima-Media and Preeclampsia 
Author Study 
Design 
Population 
& Sample 
Size 
Definition of 
Preeclampsia 
Outcome 
Assessed 
When 
Assessed 
Confounders Results 
Blaauw et al. 
(2006) 
Case-control 
Cross-
sectional 
data 
Netherlands 
Participants: 
Primiparas 
with  PE: 22 
Primiparas 
normal 
pregnancy: 22 
Nulliparas: 22 
Mean BMI 26 
Hospitalized at one 
hospital with early-onset 
PE (before 34 weeks 
EGA).  New appearance 
of DBP 90 mm Hg or 
higher measured at 2 
occasions at least 4 hours 
apart with proteinuria 
(>=300 mg/24 hours or 2+ 
dipstick) after 20 weeks.  
Very strict definition, very 
high risk group (2 had 
eclampsia, 73% IUGR). 
CCA IMT, 
Bulb IMT, 
ICA IMT, 
common 
femoral 
artery IMT, 
superficial 
femoral 
artery IMT 
bilaterally. 
3-13 months 
postpartum 
and at least 6 
weeks after 
ending 
lactation. 
Control groups 
frequency-matched 
to PE group on age, 
BMI and smoking. 
Women with PE had 
higher triglycerides 
& homocysteine. 
CCA IMT is largest in PE group (0.65), 
medium in normal pregnancy group 
(0.62 mm) & least in nulliparous group 
(0.59).  Difference between PE & 
nulliparous p = .002.  After adjustment 
for BMI, SBP, DBP, HDL, LDL, 
triglycerides, smoking & family history, 
this remains the same. 
Gaugler-
Sender et al. 
(2008) 
Case-control 
Cross-
sectional 
data 
Netherlands 
Participants:  
Women with 
severe early 
PE: 20 
Women with 
healthy 
pregnancies: 
20 
Average age: 
32 
Severe, early onset 
preeclampsia (<24 
weeks).  DBP >= 110 mm 
HG & proteinuria < 2+ on 
catheterized specimen, or 
SBP >= 140 mmHG or 
DBP >= 90 mmHg on 2 
occasional and proteinuria 
>+ 300mg/24 hours or 
>=2+ on dipstick of 
voided specimen with 
eclampsia or HELLP 
syndrome. 
Mean of 
maximum 
IMT of near 
& far wall of 
CCA 
Mean 5.5 
years from 
index 
pregnancy, 
range 4-11. 
Controls matched for 
age, parity, race and 
year of delivery. 
There were 
significant 
differences in BP, 
HTN, & 
microalbuminuria. 
BMI for cases 25.7 
vs. 22.7 for controls, 
but NS. 
Mean Max CCA IMT 0.6 mm for 
women with PE, 0.59 mm for controls. 
Only unadjusted results presented. 
Goynumer et 
al. (2013) 
Case-control 
Cross-
sectional 
data 
Turkey 
Participants: 
Women with 
severe PE: 34 
Women with 
healthy 
pregnancies: 
42 
Average age: 
30 
Severe 
preeclampsia: SBP >= 
160 mmHg or DBP >= 
110 mmHG on 2 
occasions at least 6 hours 
apart on bed rest, or 
proteinuria >= 5 g/24 
hours with HELLP 
syndrome or eclampsia.  
Also, women with end-
organ involvement. 
Mean of 3 
images from 
right and left 
CCA. 
12-24 months 
postpartum 
All non-smokers and 
mid follicular. 
Women with PE had 
greater BMI, SBP, 
DBP 
Mean CCA IMT 0.66 mm for PE, 0.62 
for controls, p = 0.025. 
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Table A.1 Continued Studies of Intima-Media and Preeclampsia 
Author Study 
Design 
Population 
& Sample 
Size 
Definition of 
Preeclampsia 
Outcome 
Assessed 
When 
Assessed 
Confounders Results 
Yuan et al. 
(2013) 
Case-control 
Cross-
sectional 
data 
China 
Participants: 
All 
nulliparous. 
Women with 
“late-PE”: 22 
Controls: 28 
Average age: 
29 
Based on guidelines of  
International Society for 
the Study of Hypertension 
in Pregnancy.  New onset 
htn after 20 weeks with 
properly documented 
proteinuria. 
RCCA using 
MylabTwice  
high 
resolution 
ultrasound 
using radio 
frequency 
signal.  IMT 
& “internal 
diameter.’ 
36 weeks 
EGA 
Controls: matched 
for age & gestational 
age. 
Cases were older, but 
NS (29 vs. 27, p = 
0.09) 
IMT results adjusted 
for BP & BMI 
Mean CCA IMT .46 mm for PE vs. .35 
for normal pregnancy, p=0.003.  After 
adjustment for MAP, NS. 
Internal diameter 7.8 mm for PE vs. 7.2 
for controls, p < 0.0001, significant after 
adjustment for BMI, SBP, DBP, or 
MAP. 
HTN = hypertension; yo = years old; BMI = body mass index; IMT = intima-media thickness; CCA = common carotid artery; PE = 
preeclampsia; MAP = mean arterial pressure;  SBP = systolic blood pressure; DBP = diastolic blood pressure; CI = confidence interval; 
EGA = estimated gestational age; IUGR = intrauterine growth restriction; ICA = internal carotid artery; HDL = high-density 
lipoprotein; LDL = low-density lipoprotein; HELLP = hemolysis, elevated liver enzymes, low platelets; RCCA = right common carotid 
artery; NS = non-significant; BP = blood pressure 
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Table A.2 Studies of Intima-Media Thickness and Gestational Diabetes 
Author Study 
Design 
Population & Sample 
Size 
Definition of 
GDM 
Outcome 
Assessed 
When 
Assessed 
Confounders Results 
Akinci et al. 
(2008) 
Case-control. 
Cross-
sectional 
data. 
Turkey 
GDM:20 
Women with normal 
GDM screens in 
previous pregnancy: 19 
2 or more 
abnormal values 
on 3 hour GTT.  
Abnormal are ≥95, 
180, 155, 140 
mg/dl. 
IMT – CCA 
bilaterally. 
3 years pp Age & BMI 
matched 
IMT = 0.56 mm for each (p=0.962) 
Akinci et al. 
(2011) 
Case-control 
Cross-
sectional 
data 
Turkey 
GDM:128 
Healthy women 
experiencing pregnancy 
in same period with 
normal GDM screens:  
67 
Age 35, BMI 28 vs. 24 
2 or more 
abnormal values 
on 3 hour GTT.  
Abnormal are ≥ 
95, 180, 155, 140 
mg/dl. 
Mean of CCA, 
bulb, ICA IMT 
bilaterally 
Mean 3 years 
pp (range1-7) 
Age matched 
Significant 
differences in 
BMI, WC, 
Glucose, all 
cholesterol 
measures, 
CRP, insulin 
Previous GDM:  IMT 0.56 mm ±0.08, 
Controls 0.52 ± 0.06 (p<0.001) 
Bayraktar et 
al.  (2012) 
Case-control 
Cross-
sectional 
data 
Turkey 
Former GDM: 81 
Insulin: 45 
No insulin: 36 
Healthy, lean women 
experiencing pregnancy 
in same period with 
normal GDM screens:  
35 
2 or more 
abnormal values 
on 3 hour GTT.  
Abnormal are ≥ 
95, 180, 155, 140 
mg/dl. 
Compared women 
achieving 
glycemic control 
with diet and 
exercise to women 
requiring insulin 
(oral anti-
glycemics not an 
option). 
CCA IMT 
bilaterally. 
3 months 
postpartum 
Age matched. 
Significant 
differences in 
BMI, WC, 
Glucose, all 
cholesterol 
measures, 
fibrinogen, 
HOMA-IR, 
CRP 
Previous GDM:  IMT 0.55 mm ±0.07, 
Controls 0.52 mm ± 0.05 (p=.014) 
Insulin:  IMT 0.57 mm  ± 0.07, no 
insulin 0.53 mm ± 0.05, control 0.52 ± 
0.05.  p = 0.007 for insulin vs. control. 
Carotid IMT positively correlated with 
BMI, glucose, CRP, IL-6. 
Fakhrzadeh 
et al. (2012) 
Case-control 
Cross-
sectional 
data 
Iran 
Former GDM: 20 
Former pregnancy 
without GDM: 20 
Exclude: present or 
former smokers, HTN, 
DM, symptomatic 
CVD 
O’Sullivan and 
Mahan criteria:  2 
or more abnormal 
values on 3 hour 
GTT.  Abnormal 
are ≥ 105, 190, 
165, 145 
Mean of 6 
measurements: 
Left and right 
CCA, bulb & 
ICA IMT. 
4 years 
postpartum 
Matched on 
BMI, age, and 
years since 
pregnancy. 
Former GDM 
NS older, 
higher parity, 
significantly 
higher insulin 
and HOMA-IR 
Previous GDM: mean IMT 0.51 mm ± 
0.09, Controls 0.48 ± 0.09, p = .02. 
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Author Study 
Design 
Population & Sample 
Size 
Definition of 
GDM 
Outcome 
Assessed 
When 
Assessed 
Confounders Results 
Freire et al. 
(2012) 
Case-control 
Cross-
sectional 
data 
Brazil 
Former GDM: 79 
Former pregnancy 
without GDM:  60 
Exclude: preeclampsia, 
smoking, addiction, 
uremia, liver, 
psychiatric, 
rheumatological or 
thyroid disease, or 
steroid use 
2 or more 
abnormal values 
on 3 hour GTT.  
Abnormal are ≥ 
95, 180, 155, 140 
mg/dl. 
Left and right 
CCA, bulb & 
ICA IMT. 
Mean of 6 
readings. 
2-3 years 
postpartum 
Significant 
differences is 
BMI, waist 
circumference, 
SBP, DBP, 
fasting glucose, 
total 
cholesterol, 
HDL-c, LDL-
c, triglycerides 
Previous GDM vs. Controls (medians): 
LCCA .53 mm vs. .50 mm, p < .05 
L bulb .61 mm vs. .57 mm, p = .001 
LICA .45 mm vs. .40 mm, p = .01 
RCCA .51 mm vs. .50 mm, NS 
R bulb .59 mm vs. .55 mm, p < .05 
RICA .45 mm vs. .40 mm, p < .05 
Composite IMT .53 vs. .49 mm, p < 
.001 
In multivariable analysis age, total 
cholesterol and prior GDM remained as 
significant predictors of composite IMT. 
Tarim et al. 
(2006) 
Case-control 
Cross-
sectional 
data 
Turkey 
Women with GDM: 30 
Unaffected pregnant 
women: 40 
Excluded: smokers, 
folic acid or vitamin 
B12 deficiency,  
hypertension, multiple 
gestation, fetal 
anomalies, diabetes, 
thyroid disease, family 
history of CVD 
2 or more 
abnormal values 
on 3 hour GTT.  
Abnormal are ≥ 
95, 180, 155, 140 
mg/dl. 
Left common 
carotid artery 
IMT. 
Mean 25 
weeks 
gestation. 
Matched on 
age and BMI. 
GDM.582 ± .066 vs. .543 ± .049, p = 
.006. 
Yousefzadeh 
et al (2012) 
Cohort 
Iran 
50 nulliparous women 
at high-risk for GDM, 
18-35, singleton.  
Excluded:  family 
history CVD, 
hypertension, 
cholesterol lowering 
medication use, 
hyperlipidemia, 
diabetes, renal or liver 
disease, cancer, recent 
hormonal medications, 
smoking, BMI > 35, 
infertility, PCOS, and 
plaque > 1.0 mm.  
Do not specify 
diagnostic criteria. 
Mean of CCA 
IMT and ICA 
IMT 
bilaterally. 
Assessed at 
24- 24 weeks 
and 36-38 
weeks 
gestation. 
Women with 
GDM non-
significantly 
greater BMI & 
higher blood 
pressure. 
25 women with GDM, 25 without. 
2nd trimester: 
GDM .65 mm ± .07 vs. non-GDM .59 
mm ± .06, p = .002. 
3rd trimester: 
GDM .65 mm ± .05 vs. .59 mm ± .04, p 
< .001. 
GDM = gestational diabetes mellitus; GTT = glucose tolerance test; IMT = intima-media thickness; CCA = common carotid artery; pp = postpartum; BMI = body mass index; ICA 
= internal carotid artery; WC = waist circumference; HOMA-IR = homeostasis model assessment of insulin resistance; CRP = C-reactive protein; IL-6 = interleukin 6; HTN = 
hypertension; DM = diabetes mellitus; CVD = cardiovascular disease; NS = non-significant; SBP = systolic blood pressure; DBP = diastolic blood pressure; HDL-c = high-density 
lipoprotein concentration; LDL-c = low-density lipoprotein concentration; LCCA = left common carotid artery; L = left; LICA = left internal carotid artery; RCCA = right common 
carotid artery; R=right; RICA = right internal carotid artery; PCOS = polycystic ovary syndrome. 107 
Table A.3 Studies of Arterial Stiffening and Preeclampsia 
Author Study 
Design 
Population & 
Sample Size 
Pregnancy Complication Outcome 
Assessed 
When 
Assessed 
Confounders Results 
Anastasakis 
et al. (2008) 
Cross-
sectional 
Greece 
40 women with 
healthy 
singleton 
pregnancies 
34 with normal 
uterine artery 
pulsatility 
6 developed 
preeclampsia 
Preeclampsia:  DBP ≥ 110 
mmHg on 1 occasion or 
DBP ≥ 90 mm Hg on 2 
occasions at least 4 hours 
apart, with urinary protein  
≥ 300 mg/24 hours or ≥ 2 
by dipstick on 2 
consecutive occasions at 
least 4 hours apart 
developing after 20 weeks 
gestation in previously 
normotensive women. 
crPWV 20-23 weeks 
gestation 
No adjustment 
made.  SBP 
higher in women 
with PE. 
crPWV 9.11 m/s ± 1.26 for normal 
Doppler vs. 9.08 m/s ± 1.51  for women 
with preeclampsia, p = .636. 
Evans et al. 
(2011) 
Cross-
sectional 
United States 
50 women with 
previous 
uncomplicated 
pregnancies. 
18 women with 
pregnancies 
with 
preeclampsia 
Preeclampsia:  SBP ≥ 140 
mmHG or DBP ≥ 90 
mmHG with proteinuria 
(≥ 300 mg/24 hours or ≥ 
2+  by dipstick on voided 
sample or ≥+1 on 
catheterized sample or 
spot urine 
protein/creatinine ratio > 
.3) with hyperuricemia 
after 20 weeks of 
pregnancy in previously 
normotensive women.   
Heart-to-
brachial 
PWV 
16 months 
postpartum 
DBP and TVR 
higher in 
previously 
preeclamptic 
women. 
Heart-to-brachial PWV 374 cm/s ± 8 for 
normal vs 405 cm/s ± 20 for women 
with previous preeclampsia, p = .061. 
Kaihura et al. 
(2009) 
Cross-
sectional 
England 
69 
normotensive 
pregnant 
women 
54 women with 
preeclampsia, 7 
with 
preexisting 
chronic 
hypertension, 
20 early-onset 
(before 34 
weeks.) 
Preeclampsia:  DBP ≥ 110 
mmHg on 1 occasion or 
DBP ≥ 90 mm Hg on 2 
occasions at least 4 hours 
apart, with urinary protein  
≥ 300 mg/24 hours or ≥ 2 
by dipstick on 2 
consecutive occasions at 
least 4 hours apart 
developing after 20 weeks 
gestation in previously 
normotensive women. 
crPWV Healthy 
pregnancies: 
31 weeks 4 
days ± 36 
days 
Early-onset 
PE: 28 weeks 
4 days ± 23 
days 
Late-onset 
PE:  36 weeks 
3 days ± 12 
days 
46 women with 
PE on anti-
hypertensive 
medications.  
State results 
similar when 
women on beta 
blockers 
excluded. 
Different 
gestational ages. 
Blacks over-
represented in 
early PE group. 
crPWV 9.3 m/s ± 0.7 for early PE, 9.5 
m/s ± 1.1 for late PE, and 7.5 m/s ± 1.2 
for healthy pregnancy, p =< .0001 for 
PE vs. healthy, p = .4 for early vs. late 
PE. 
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Table A.3 Continued Studies of Arterial Stiffening and Preeclampsia 
Author Study 
Design 
Population & 
Sample Size 
Pregnancy Complication Outcome 
Assessed 
When 
Assessed 
Confounders Results 
Oyama-Kato 
et al. (2006) 
Longitudinal 
Japan 
183 women 18-
39. 16
developed PIH.  
No multiples, 
chronic 
hypertension, 
hyperlipidemia, 
diabetes 
mellitus, 
smokers. 
PIH:  SBP ≥ 140 mmHG 
or DBP ≥ 90 mmHG with 
or without proteinuria (  ≥ 
300 mg/24 hours or ≥ 2 by 
dipstick) after 20 weeks of 
pregnancy in previously 
normotensive women.   
baPWV Pregnancy: 9-
14 weeks, 21-
29 weeks, 32-
39 weeks. 
Postpartum: 
3-5 days, 1 
month. 
Women in PIH 
group were older 
and had greater 
BMI. 
Women in both groups had equivalent 
baPWV in 1st trimester.  For women 
with healthy pregnancies, this dropped 
in 2nd trimester and remained decreased 
3rd trimester.  For women with PIH 
there was no 2nd trimester drop.  Values 
were significantly higher for women 
with PIH in 2nd & 3rd trimesters and 
immediately postpartum. 
Robb et al 
(2009) 
Longitudinal 
Scotland 
22 healthy, 
nulliparous, 
non-smoking 
women.  No 
hypertension, 
medication use, 
pregnancy 
complications. 
15 women with 
preeclampsia. 
Preeclampsia:  SBP ≥ 140 
mmHG or DBP ≥ 90 
mmHG with proteinuria 
(≥ 300 mg/24 hours or ≥ 1 
by dipstick or spot urine 
protein/creatinine ratio > 
30 mg protein/mmol 
creatinine) after 20 weeks 
of pregnancy in 
previously normotensive 
women.   
crPWV Normal: 16, 
24, 32 & 37 
weeks of 
pregnancy & 
7 week 
postpartum 
Preeclampsia:  
after 
diagnosis & 7 
weeks 
postpartum 
Women with 
preeclampsia 
were shorter. 
7 women in 
preeclampsia 
group taking 
anti-hypertensive 
medications, 6 
received 
bethamethasone 
crPWV was higher in women with 
preeclampsia when matched to women 
with normal pregnancy by gestational 
age (p≤.006).  No difference by 7 weeks 
postpartum. 
Spaanderman 
et al. (2000) 
Longitudinal 
The 
Netherlands 
42 women with 
history of 
preeclampsia 
10 healthy 
parous controls 
No: vitamins, 
oral 
contraceptives, 
blood pressure 
medications, 
NSAIDS or 
glucocorticoids 
Preeclampsia: ISSHP 
guidelines  
Femoral 
artery 
compliance 
measured 
with B-mode 
ultrasound.  
Distensibility 
coefficient. 
Pre-
pregnancy, 5 
& 7 weeks of 
pregnancy 
No difference at 5 week.  At 7 weeks 
women with preeclampsia but no 
underlying disorder had lower 
distensibility (6.1 kPa-1 ± 2.0 vs. 10.6 
kPA-1 ± 4.1, p<.05). 
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Author Study 
Design 
Population & 
Sample Size 
Pregnancy Complication Outcome 
Assessed 
When 
Assessed 
Confounders Results 
Spaanderman 
et al. (2005) 
Longitudinal 
The 
Netherlands 
31 women with 
history of 
preeclampsia, 
currently 
normotensive, 
achieving 
pregnancy 
within 1 year.  
Non-smokers. 
Preeclampsia:  SBP ≥ 140 
mmHG or DBP ≥ 90 
mmHG with proteinuria 
(≥ 300 mg/24 hours) after 
20 weeks of pregnancy in 
previously normotensive 
women.   
SGA: birth weight below 
10th percentile 
Femoral 
artery 
compliance 
measured 
with B-mode 
ultrasound.  
Distensibility 
coefficient. 
Follicular 
phase of 
menstrual 
cycle.  2.3 
years since 
pregnancy. 
Femoral artery distensibility: 
AGA: 6.4 kPa-1  (2.7-11.1) 
SGA: 8.8 kPa-1 (5.1-17.0), p <.05. 
 
 
DBP = diastolic blood pressure; crPWV = carotid-radial pulse wave velocity; DBP = diastolic blood pressure; PE = preeclampsia; 
SBP = systolic blood pressure; PWV = pulse wave velocity; TVR = total vascular resistance; PIH = pregnancy-induced hypertension; 
baPWV = brachial-ankle pulse wave velocity; BMI = body mass index; SGA= small for gestation age; AGA = appropriate for 
gestational age. 
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